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Die Entdeckungen der letzten Zeit lassen praktisch alles, was wir viele Jahre für richtig 
gehalten haben, als falsch oder nur bedingt richtig erscheinen. Meiner Meinung nach kann 
man heute nur noch eines mit Sicherheit sagen: Die Lichtgeschwindigkeit ist absolut das 
Schnellste, was es gibt. Möglicherweise. 
 
Edward Teller 
ABSTRACT 
 
Basement membranes are thin layers of extracellular matrix which separate epithelial and 
endothelial cells from underlying connective tissue and surround nerve, muscle and fat cells. 
Biochemical data indicate the important role of nidogen-1, a 150kD sulfated glycoprotein, in 
supporting basement membrane stability by connecting the laminin and type IV collagen 
network (Aumailley et al., 1989; Yurchenco and Schittny, 1990). 
 
The aim of this study was to analyse the significance of the laminin/nidogen-1 interaction for 
basement membrane formation and stability in a more complex system. For that purpose F9 
embryoid bodies, a cell culture model for basement membrane formation, were grown in the 
cell spin system after comparison with the conventional hanging drop method. F9 cells are 
mouse teratocarcinoma cells which differentiate and develop a basement membrane when 
cultured with retinoic acid. 
 
Recombinant expression of the nidogen-binding site, located in LE module 4 of the g1 chain 
of the trimeric laminin molecule, as the g1III3-5 fragment and its binding to free nidogen-1 
molecules should interfere with the laminin/nidogen-1 interaction. As controls, F9 cells were 
transfected with the empty expression vector, the g1V1-3 and the g1III3-5mut fragment. 
g1V1-3 is similar to the g1III3-5 fragment in secondary structure and size while g1III3-5mut 
carries a point mutation drastically reducing its affinity to nidogen-1. For detection of 
recombinant expression and for purification purposes all constructs had been modified with 
the FLAG peptide at their N-terminal end. 
 
Analysis of basement membrane formation by fluorescence microscopy revealed a different 
pattern in clones expressing the nidogen-binding site than in the controls. While cells carrying 
the empty expression vector and such expressing the g1V1-3 or the g1III3-5mut fragment 
developed embryoid bodies with completely or partially continuous basement membranes, 
only a punctate distribution of basement membrane components could be detected in cell 
aggregates expressing the nidogen-binding site. This indicated effective blocking of the 
laminin/nidogen-1 interaction by recombinant expression of the g1III3-5 fragment. Additional 
studies on differentiation showed patchy distribution of cells expressing genes specific for 
visceral endoderm all over the embryoid body. In the controls these cells were organised into 
an peripheral epithelium which suggests a role of basement membranes in regulating the 
differentiation of these cells. To evaluate further functional aspects of the basement mem-
brane discontinuity a diffusion assay was developed in which permeability properties could be 
tested. This revealed higher permeabilities among clones with comparable embryoid body 
morphologies when the basement membrane was disrupted. 
 
To exclude the possibility that endogenous recombinant expression or the genetic mani-
pulation during transfection was responsible for the observed phenotypes, experiments were 
also performed with the extraneous addition of the recombinant nidogen-binding site. Wild 
type F9 cells were grown in suspension culture and treated with recombinantly expressed, 
affinity purified nidogen-binding site fragment. Microscopy demonstrated a similar basement 
membrane breakdown upon exogenous addition of the nidogen-binding site as observed be-
fore in embryoid bodies derived from F9 cells recombinantly expressing the g1III3-5 frag-
ment. 
ZUSAMMENFASSUNG 
 
Basalmembranen sind dünne Schichten extrazellulärer Matrix, die Epithel- und Endothel-
zellen vom Bindegewebe trennen und Nerven-, Muskel- und Fettzellen umgeben. Eine auf 
biochemischen Daten (Aumailley et al., 1989) gestützte Hypothese erklärt die Stabilität der 
Basalmembran mit Nidogen-1, einem 150kD großen sulfatierten Glykoprotein, als Bindeglied 
zwischen dem Laminin- und Typ IV Kollagen- Netzwerk der Basalmembran (Yurchenco und 
Schittny, 1990). 
 
Ziel war es, die Bedeutung der Laminin/Nidogen-1 Wechselwirkung für die Ausbildung und 
Stabilität von Basalmembranen in einem komplexeren System zu analysieren. Dafür wurde 
ein Zellkultur-Modell der Basalmembranbildung, das F9 Zellaggregatsystem, nach Ver-
gleichen mit der "Hanging Drop"-Methode in Spinnerflaschen etabliert. Solche "Embryoid 
Bodies" aus F9 Maus Teratokarzinomazellen bilden bei Retinsäurebehandlung eine Basal-
membran aus. 
 
Rekombinante Expression der in LE Modul 4 der g1 Kette des trimeren Laminin Moleküls 
lokalisierten Nidogenbindungsstelle im Fragment g1III3-5 und dessen Bindung an freie 
Nidogen-1 Moleküle sollte das natürliche Gleichgewicht der Laminin/Nidogen-1 Interaktion 
stören. Als Kontrollen wurden neben dem leeren Expressionsvektor ein der Nidogen-
bindungsstelle in Sekundärstruktur und Größe ähnliches Fragment der g1 Kette, g1V1-3, 
sowie eine mutierte Version der Nidogenbindungsstelle g1III3-5mut in F9 Zellen transfiziert. 
Zuvor waren alle Konstrukte zum Nachweis rekombinanter Expression und um eine Auf-
reinigung zu ermöglichen mit einem N-terminalen FLAG Bindungsmodul versehen worden. 
 
Die mikroskopische Untersuchung der die Nidogenbindungsstelle exprimierenden Klone 
ergab eine von den Kontrollen abweichende Ablagerung der Basalmembranproteine. 
Während die nur resistente Kontrolle sowie die g1III3-5mut und g1V1-3 synthetisierenden 
"Embryoid Bodies" entweder durchgehend oder wenigstens streckenweise Basalmembran 
ausbilden konnten, war in den die Nidogenbindungsstelle exprimierenden Klonen nur eine 
punktförmige Verteilung von Basalmembrankomponenten zu erkennen. Dies sprach für eine 
effiziente Blockierung der Laminin/Nidogen-1 Wechselwirkung durch die rekombinante 
Expression des g1III3-5 Fragments. Die zusätzliche Bestimmung der Fähigkeit zur Differen-
zierung zeigte, dass in dem Klon mit gestörter Basalmembranausbildung Zellen mit einer für 
das viscerale Endoderm spezifischen Genexpression über das ganze Zellaggregat verteilt 
waren. In den Kontrollen hingegen waren solche Zellen vorzugsweise an der äußeren 
Peripherie in einem Epithel organisiert, was eine Funktion der Basalmembran in der Steuer-
ung der Zelldifferenzierung impliziert. Um die mikroskopisch erkennbare Zerstörung der 
Basalmembran auf ihre funktionelle Konsequenz hin zu testen, wurden ihre Permeabilitäts-
eigenschaften mit der Diffusions-Messmethode bestimmt. Daraus ergab sich für "Embryoid 
Bodies" mit vergleichbarer Morphologie eine höhere Permeabiliät bei gestörter Basalmem-
branausbildung. 
 
Weil die Möglichkeit bestand, dass die den Zellmetabolismus belastende rekombinante Ex-
pression oder klonale Selektion ausschlaggebend für die beobachteten Phänotypen waren, 
wurde außerdem in Suspensionskulturen herangezogene Wildtyp F9 "Embryoid Bodies" in 
mit rekombinant erzeugten, affinitätsgereinigten Nidogenbindungsstellen versetztem Medium 
differenziert. Deren mikroskopische Analyse zeigte bei Zugabe der Bindungsstelle von außen 
dieselbe Störung der Basalmembranausbildung wie sie zuvor bei den Klonen mit endogener 
rekombinanter Expression beobachtet worden war. 
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1. Introduction 
 
1.1. The evolution of extracellular matrices 
 
During the development from uni- to multi-cellularity novel structural requirements 
were placed upon the evolving organisms. A primary need was the maintenance of the body 
form. While in primitive organisms this could probably be met by receptor mediated cell-cell 
contacts, these became insufficient as size and complexity increased leading to the evolution 
of the extracellular matrix. Although it is uncertain which extracellular matrix function 
evolved first, it may be speculated that the underlying need was to provide physical support to 
maintain the integrity of the body and that this finally led to the production of a prototype 
connective tissue and, particularly, the evolution of the collagen family (van der Rest and 
Garrone, 1991; Garrone, 1998). Here great tensile strength is produced through the close 
intramolecular association supplied by the triple helix and intermolecular covalent bonds. 
With specialisation of cells into tissues, it became necessary to evolve modes of compartmen-
talisation (Kleinman and Schnaper, 1993). The physical barrier separating cell and tissue 
types led to the formation of the architechtural framework of higher organisms. To transmit 
this stabilisation from the extracellular scaffold to the cell, specialised areas may have 
developed containing receptor molecules anchoring the intracellular skeleton to particular 
molecules in the surrounding matrix. These receptors were possibly refined to also allow 
signalling between the matrix and the cells and vice versa. So external events were not only 
conveyed by soluble proteins, which may themselves be bound into the matrix, as is the case 
with many cytokines, but also by the structural components themselves. This has led to the 
extracellular matrix having key roles in the presentation of growth and guidance cues to cells, 
which can in turn influence the secretion of extracellular matrix components. So, cell-matrix 
contacts may determine cellular differentiation. This has become crucial for most normal de-
velopmental processes such as gastrulation (Czaker, 2000), neural crest formation (Poelmann 
et al., 1990) and whether a cell or axon migrates, where it goes and when it stops migrating, 
as well as for adult physiology and pathology (e.g. extravasation of white blood cells, meta-
stasis, wound healing). In addition to directing cellular motility, the extracellular matrix con-
trols the formation of tissues like bone, cartilage, and tendon with characteristic structural pro-
teins and growth factors. The latter contribute by establishing gradients of guidance cues in 
which cells can orientate, differentiate and secrete those extracellular matrix components 
serving the specific needs of each tissue. 
1 
Most studies of the extracellular matrix have been performed on vertebrate organisms, 
however investigations of invertebrates show that many extracellular matrix components are 
ancient and highly conserved proteins. For example, the fibril-forming collagens I, II, III and 
V , providing tensile strength, as well as the non-fibrillar collagen type IV of basement mem-
branes are found in invertebrate organisms like sponges, worms and mussels (Coyne et al., 
1997; Kramer et al., 1994; Garrone et al., 1993). However broad the spectrum of identified 
collagen homologs seems to be, little is known about the mechanisms behind their evolution 
(Engel, 1997). Ancestor proteins have also been found for molecules presenting information 
in the extracellular matrix. Perlecan (Laurie et al., 1986), a basement membrane proteoglycan 
of higher organisms, is also a cartilage component and plays an important role in chondro-
genic differentiation probably by binding and presenting growth factors (French et al., 1999). 
However, closely related proteoglycans are also present in primitive invertebrate organisms 
such as C. elegans and the fruit fly, where an ortholog of perlecan (Mullen et al., 1999; 
Moerman et al., 1996) and a perlecan-like core protein sequence have been identified 
(Friedrich et al., 2000), respectively. Since primitive organisms do not have cartilage these 
findings are an example of how the roles of extracellular matrix proteins may be adapted to 
new functions during evolution. 
 
Modern extracellular matrix proteins are mosaic proteins consisting of about 65 
different domains (Bork, 2000). It has been suggested that they arose by exon shuffling 
(Patthy, 1996), a good example of which could be the mammalian nidogen-1. The earliest 
nidogen is seen in ascidians and contains three epidermal-growth-factor (EGF)-like motifs, 
three thyroglobulin-like motifs and five LDL-receptor YWTD domains (Nakae et al., 1993). 
Through evolution three extra cysteine-rich epidermal-growth-factor (EGF)-like motifs have 
been added by exon shuffling and one thyroglobulin-like motif was achieved by combination 
of three ancestral ones. Further highly conserved homologs of nidogen are observed in fruit 
flies, nematodes and sea squirt (Mayer et al., 1998). Another example where gene duplication 
appears to have occurred is the laminin protein family, mainly present in basement mem-
branes. Laminins are heterotrimeric glycoproteins consisting of three genetically different 
chains. Today eleven distinct chains and fifteen different laminin isoforms are known in 
mammals. Identification of two laminin chains in Drosophila (Fessler et al., 1987; Martin et 
al., 1999), four laminin chains (Hutter et al., 2000) and the laminin-related netrins 
(Wadsworth et al., 1996) in C.elegans strongly imply the existence of a single ancestral 
laminin chain which has duplicated further within the vertebrate lineage. 
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1.2. Basement membrane structure and function 
 
Basement membranes are 40 to 120nm thick sheets of extracellular matrix found 
throughout the body. They line the basolateral membrane of all epithelial and endothelial 
cells, separate them from the underlying connective tissue and surround nerve, muscle and fat 
cells. Basement membranes may interpose between endothelial and epithelial cell sheets as in 
the lung alveoli and kidney glomeruli. In the kidney, the basement membrane functions as a 
porous filter, preventing the passage of macromolecules from blood into urine. Basement 
membranes beneath epithelia prevent the contact between fibroblasts and epithelial cells, but 
allow the passage of macrophages, lymphocytes or nerve processes. In addition, basement 
membranes play an important role during development, binding growth factors and hormones 
which influence cell metabolism, cell growth, cell polarisation, and differentiation (Streuli et 
al., 1991; Schuger et al., 1997). The ability of certain basement membrane molecules to inter-
act with cell surface receptors allows it to direct cell migration during development or to help 
to reconstruct original tissue architecture (e.g. guidance of regenerating motor nerve terminals 
to neuromuscular junctions) after tissue injury. All these different basement membrane func-
tions imply tissue- and time-specific expression of its components from embryogenesis to 
adulthood. Some of these basement membrane molecules will be discussed below in detail. 
 
 
 
1.3. Basement membrane components 
 
1.3.1. Laminins 
 
1.3.1.1. Laminin isoforms 
 
The laminins are large (600-800kD), cruciform glycoproteins (Tunggal et al., 2000) 
consisting of three genetically different chains (a, b  and g) which share a common domain 
structure (figure 1.1). The short arms formed by the amino-terminal regions of the b  and g 
chains contain the domains III and IV instead of domains IIIa/b and IVa/b found in the a 
chains (Sasaki and Yamada, 1987; Sasaki et al., 1987, 1988). These biologically active 
domains are separated by flexible rows of EGF-like repeats, the LE motifs, which are stabi-
lised by disulfide bonds. The long arm results from oligomerisation through a triple helix of 
3 
domains I and II of the a, b  and g chain. At the carboxy-terminal end of the a chains the large 
G domain is formed by folding of the five tandemly arranged subdomains LG1-LG5 into 
separate globes. 
 
Five a-, three b- and three g- chains have been identified in mammals which could in 
theory be combined to give 45 cruciform heterotrimers. However due to additional assembly 
restrictions (e.g. g2 is never seen connected with b1) only 15 laminin isoforms have been 
observed although more forms may well exist (Colognato and Yurchenco, 2000; Libby et al., 
2000). Studies on the assembly of laminin chains indicate that certain sites within the 
carboxy-terminal a-helical region of the long arm are important for chain-specific assembly 
(Utani et al., 1994). Little is known about the mechanism of chain secretion in vivo, but cell 
culture studies demonstrate that the a chain can be secreted as a single subunit while b  and g 
can not (Yurchenco et al., 1997). 
 
 
 
Figure 1.1: Schematic structure of the laminin molecule comprising an a, b and g chain. The molecule has a cruci-
form shape (Engel et al., 1981) with three short amino-terminal arms which are involved in polymerisation. The 
long carboxy -terminal arm consists of domain I and II of all three chains and forms a coiled-coil a-helix 
(Paulsson et al., 1985; Beck et al., 1993) which is terminated by a globular carboxy -terminal domain (G) contri-
buted by the a chain only. The three-stranded coiled-coil domain is required for high-affinity binding to agrin 
(Kammerer et al., 1999). a1b1, a2b1, a6b1, and a7b1 indicate integrin binding sites. Other binding partners in-
dicated are dystroglycan (DG), the polysaccharide heparin and nidogen-1/entactin-1. 
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An overall picture of the time- and tissue-specific deposition of laminin isoforms does 
not exist at the moment, because immunohistology and in situ hybridisations can only 
describe the distribution pattern of single laminin chains but not of the whole trimer. Still, 
three classes of epithelial laminins containing either the a1, a3 or a5 chain and the group of 
endothelial or mesenchymal laminins comprising the a2 chain or the a4 chain can be disting-
uished (see table 1). So laminins-1, -3, -5, -6, -7, -10 and -11 underly epithelial structures 
while laminins-2, -4 and -12 are observed in the placenta (Paulsson et al., 1991), in basement 
membranes surrounding skeletal and cardiac muscles (Leivo and Engvall, 1988; Paulsson et 
al., 1991) and peripheral nerves (Uziyel et al., 2000). Laminins-8 and -9 are found in endo-
thelial basement membranes of certain blood vessels, e.g. aorta (Frieser et al., 1997). The a4 
chain is also expressed by skeletal, cardiac muscle (Lefebvre et al., 1999; Liu and Mayne, 
1996) as well as fat cells (Niimi et al., 1997a). Recent data indicate the existence of two addi-
tional isoforms, laminin-14 and -15, present in the retinal matrix (Libby et al., 2000). The on-
going identification of new laminin isoforms increases basement membrane complexity not 
only in tissue-specific composition, but also during development and repair (Erickson and 
Couchman, 2000). 
 
 
Name Chain composition References 
Laminin-1 a1b1g1 Timpl et al., 1979 
Laminin-2 a2b1g1 Ehrig et al., 1990 
Laminin-3 a1b2g1 Hunter et al., 1989a 
Laminin-4 a2b2g1 Sanes et al., 1990 
Laminin-5 a3b3g2 Rousselle et al., 1991 
Laminin-6 a3b1g1 Marinkovich et al., 1992 
Laminin-7 a3b2g1 Champliaud et al., 1996 
Laminin-8 a4b1g1 Miner et al. 1997 
Laminin-9 a4b2g1 Miner et al., 1997 
Laminin-10 a5b1g1 Miner et al., 1997 
Laminin-11 a5b2g1 Miner et al., 1997 
Laminin-12 a2b1g3 Koch et al., 1999 
Laminin-13 a3b2g3 * 
Laminin-14 a4b2g3 Libby et al., 2000 
Laminin-15 a5b2g3 Libby et al., 2000 
* not yet biochemically demonstrated 
 
 
Table 1. Nomenclature of laminin isoforms (modified from Tunggal et al., 2000) 
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Basement membrane composition becomes even more complex when considering 
isoform expression changes during embryogenesis. Such switches can occur very rapidly as in 
the conversion of mesenchyme to epithelium in the developing kidney (Ekblom et al., 1998; 
Miner and Li, 2000; Pedrosa-Domellof et al., 2000). The first sign of conversion into 
epithelium in vitro is the condensation of mesenchyme, followed by tubulogenesis with form-
ation of an underlying basement membrane and cell polarisation. Formation of distinct tubules 
and cell polarisation correspond to the S-shaped stage of in vivo development. Studies of a 
chain expression during this process revealed that the a4 chain is transiently expressed in 
condensated mesenchyme, followed by a1 and a5 chain expression in S-shaped tubules and 
their elongations, respectively. 
 
Laminin-1 is the major laminin essential for early embryogenesis (Dziadek and Timpl, 
1985; Leivo et al., 1980; Cooper and MacQueen, 1983). The deletion of the LAMC1 gene 
encoding the g1 chain results in absence of laminin-1 and embryonic lethality at day 5.5 post 
conceptum (Smyth et al., 1999). In its long arm structure (Aumailley et al., 1987) laminin-1 
possesses cell-binding domains as well as sites for cell adhesion and stimulation of neurite-
like outgrowth (Powell et al., 2000; Weston et al., 2000). The stimulatory effect of laminin on 
neurons is further supported by experimental data which demonstrated that laminin in neuron-
extracellular matrix interaction prevents hippocampal cell death (Chen and Strickland, 1997). 
In addition to its growth promoting activities laminin-1 was shown to modify the behavior of 
growth cones in Xenopus (Hoepker et al., 1999) possibly via induction of microtubular bund-
ling in the growth cone of axons (Tang and Goldberg, 2000). Our understanding of laminin-1 
as a basement membrane molecule specifically directing cell components is further supported 
by the discovery that it can organise acetylcholine receptors into clusters during synaptogen-
esis at the neuromuscular junction (Sugiyama et al., 1997). 
 
1.3.1.2. Laminin receptors  
 
There appear to be two major sets of laminin receptors comprising a-dystroglycan and 
the integrins. The major binding sites for both receptors on the laminin molecule are located 
within the five subdomains of the G domain (Hohenester et al., 1999; Talts et al., 2000), 
however the ones for integrin are believed to also require the adjacent coiled-coil region 
consisting of the a1, b1 and g1 chain for proper folding (Aumailley et al., 1987; Goodman et 
al., 1987; Tisi et al., 2000). 
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a-Dystroglycan is part of a large transmembrane complex that plays an important role 
in muscle biology (Ervasti and Campbell, 1993; Hemler et al., 1999). It links laminin-2 to the 
myofiber cytoskeleton via indirect binding to dystrophin and blocking of this interaction with 
antibodies induces a dystrophic phenotype (Brown et al., 1999). Dystroglycan is expressed in 
developing and adult tissues by epithelial and neuronal cells which contact basement 
membranes (Matsumura et al., 1993; Durbeej et al., 1998) and is involved in kidney epithelial 
morphogenesis (Durbeej et al., 1995). The absence of dystroglycan leads to an embryonic 
lethality with structural and functional defects of one of the earliest basement membranes, the 
Reichert's membrane (Williamson et al., 1997), and analysis of dystroglycan null embryoid 
bodies shows disrupted basement membranes (Henry and Campbell, 1998). 
 
Integrins are heterodimeric transmembrane molecules containing an a and a b  subunit 
and are involved in signal transfer between the extracellular matrix and the cell interior 
(Hynes, 1992; Clark and Brugge, 1995). Only a subset of all known integrins, the a7, a6 and 
a3 integrins seem to specifically interact with the G domain (Belkin and Stepp, 2000). a6b4 
integrin is found in hemidesmosomes whereas a6b1 integrins are often localised in focal 
contacts (Sonnenberg, 1992). For the integrins a1b1 and a2b1 the binding site was identified 
on the short arm of the laminin-1 molecule (Languino et al., 1989; Goodman et al, 1991), but 
it remains controversial if corresponding binding sites exist on other laminin isoforms (Pfaff 
et al., 1994; Colognato et al., 1997). a7b1 integrin is also laminin-specific and expressed 
highly in myoblasts (Von der Mark, 1991) together with a-dystroglycan. b1 integrin null 
embryoid bodies exhibit failures of basement membrane formation (Faessler and Meyer, 
1995; Aumailley et al., 2000) a similar phenotype can also be observed in skin epithelium 
after conditional targeting of the b1 integrin gene (Raghavan et al., 2000). Similar phenotypes 
can be caused by mutations in the a3, a6, b4 integrin subunits (George-Labouesse et al., 
1996; Niessen et al., 1996; DiPersio et al., 1997) and in syndecan-2, a heparan sulphate 
proteoglycan (Klass et al., 2000). 
 
Major functions of laminin receptors are in cell attachment and in providing signals 
which are transferred to intracellular signal cascades. However, many results also indicate that 
laminin receptors facilitate in situ laminin deposition on the cell surface as it has been demon-
strated for a-dystroglycan (Montanaro et al., 1999). Laminin polymerisation, a requirement 
for basement membrane formation in turn induces redistribution of dystroglycan, a7b1 
integrin and the cortical cytoskeleton of muscle cells (Colognato et al., 1999). 
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1.3.1.3. Laminin polymerisation 
 
The three-arm interaction model of laminin polymerisation proposes that laminin 
molecules self-assemble above a critical concentration of 0.1µM through reciprocal, calcium-
dependent binding at their amino-terminal short arms leading to the formation of large poly-
mers (Yurchenco et al., 1985; Paulsson et al., 1988; Ancsin and Kisilevsky, 1996). This inter-
action is conformation-dependent (Yurchenco and Cheng, 1994) and leaves the long laminin 
arms free for cell contacts. It is unknown whether in vivo laminin networks also contain 
heterogenous isoforms, but theoretically laminin-1 and -2 could co-polymerise (Cheng et al., 
1997). Studies on the influence of lipid bilayers on laminin polymerisation suggest that 
plasma membranes could enhance aggregation of laminin molecules. The concentration 
critical for assembly was believed to be lowered by binding of laminins to lipid bilayers (Kalb 
and Engel, 1991). Although the association with cell surface receptors rather than exposed 
lipids was considered as a possible mechanism of enhancing polymerisation, recent in vitro 
evidence demonstrates that simple acidification of laminin monomer solution induces poly-
merisation (Freire and Coelho-Sampaio, 2000). 
 
 
 
 
 
Figure 1.2: Three-arm interaction model of laminin polymerisation (Yurchenco and Cheng, 1994). The short 
arms of the a, b and g chain (continuous lines) are represented with globules at their amino-terminal ends. These 
can interact with each other in a calcium-dependent fashion in vitro . In this model the long arm (broken line) is 
free for interactions with cells. 
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1.3.2. Nidogens  
 
Nidogen-1, a sulfated 150kD glycoprotein, was first isolated from F9 mouse terato-
carcinoma cells and at that time called entactin (Hogan et al., 1980; Carlin et al., 1981). 
Differentiation of F9 cells with retinoic acid and dibutyryl cAMP induced synthesis of 
laminin-1 and nidogen-1. As shown by co-precipitation laminin-1 and nidogen-1 were in a 
complex that could be dissociated with sodium dodecyl sulfate. At the same time a protein 
which later proved to be identical with entactin was identified as a 80kD fragment in 
basement membranes of the Engelbreth-Holm-Swarm tumor and named nidogen (Timpl et al., 
1983). The full-length, 150kD form of nidogen-1 could be purified with laminin-1 by EDTA 
extraction (Dziadek et al., 1985; Paulsson et al., 1987). Analysis of large amounts of the intact 
laminin-1/nidogen-1 complex purified from the extracellular matrix showed that the two 
proteins occur in an equimolar ratio (Paulsson et al., 1987). Data obtained from electron 
microscopy confirmed the interaction between laminin-1 and nidogen-1 (Paulsson et al., 
1987) and binding studies with proteolytic fragments of the laminin-1/nidogen-1 complex 
indicated that the carboxy-terminus of nidogen-1 is responsible for binding laminin-1 (Mann 
et al., 1988). Electron microscopy of recombinant nidogen-1 showed three globular domains, 
G1 to G3, with G1 and G2 connected by a flexible link and G2 to G3 by a rod-like segment 
containing a series of EGF-like repeats (Mann et al., 1989; Durkin et al., 1995). The strong 
binding to laminin-1 with a KD of 0.5nM was found to be mediated by the C-terminal G3 
domain (Fox et al., 1991). 
 
The nidogen-binding site on laminin-1 was localised to LE module 4 within domain 
III of the laminin g1 chain (Gerl et al., 1991; Mayer et al., 1993; Poeschl et al., 1996). This 
part of the g1 chain could be crystallised (Stetefeld et al., 1996) and structurally analysed 
(Baumgartner et al., 1996). 
 
A typical EGF-like LE module forms a rigid structure. The rigidity is given by eight 
non-contiguously arranged cysteines which interact via disulfide bridges (figure 1.3). This 
leads to formation of four loops as observed in the nidogen-binding site module g1III4 
between the 1st and 3rd cysteine, the 2nd and 4th, and two further between the 5th and 6th 
and the 7th and 8th. The heptapeptide sequence Asn-Ile-Asp-Pro-Asn-Ala-Val located within 
the first loop was found to be crucial for binding to nidogen-1 (Poeschl et al., 1994) in 
combination with hydrogen bonding between the first and third loop providing binding struc-
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tures and conformational stability (Stetefeld et al., 1996). Exchange of the central Asn and 
Val by Ser leads to a 100.000 fold lower binding affinity. Such an exchange has occurred in 
the corresponding domain g2III4 of laminin-5 (a3b3g2) despite the high overall sequence 
identity between the g1III4 and g2III4 motifs (Mayer et al., 1995) and laminin-5 can 
accordingly not bind nidogen-1. 
 
 
 
Figure 1.3: The interaction between laminin-1 and nidogen-1. Nidogen-1 binds with its globular domain G 3 to the 
short arm of the g1 chain. The nidogen-binding site, LE module 4 of the g1 chain, is shown enlarged together with 
the neighbouring LE mocules. LE modules contain eight cysteines residues which upon disulfide bonding form 
loops similar to those of EGF (Cooke et al., 1987). 
 
 
In vitro binding assays indicate the ability of nidogen-1 to mediate complex formation 
between laminin and collagen type IV and also between laminin-1 and the proteoglycan 
perlecan (Aumailley et al., 1993; Hopf et al., 1999). Nidogen-1 can further bind fibulins, 
extracellular matrix proteins composed of multiple arrays of epidermal growth-factor like 
modules similar to the LE modules of laminin (Adam et al., 1997). If the interaction between 
laminin and nidogen-1 is blocked by antibodies raised against the nidogen-binding site, in 
vitro epithelial development in organ cultures of embryonic kidney and lung gets disrupted 
(Ekblom et al., 1994). Similar in vitro experiments performed with submandibular gland 
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organ cultures lead to disruption of the basement membrane between epithelium and 
mesenchyme and reduced branching epithelial morphogenesis (Kadoya et al., 1997). These 
results suggest that the formation of the laminin/nidogen-1 complex may be a key event 
during epithelial development. Detailed analysis of the sites of laminin-1 and nidogen-1 gene 
expression by in situ hybridisation (Dong and Chung, 1991; Thomas and Dziadek, 1993; 
Ekblom et al., 1994, Fleischmajer et al., 1995) have revealed that laminin-1 is predominantly 
produced by epithelial cells while nidogen-1 is secreted by mesenchymal cells. The binding of 
mesenchymal nidogen-1 to epithelial laminin-1 is believed to occur at the interface between 
epithelial and mesenchymal tissues where basement membrane formation could be dependent 
on complex formation between laminin-1 and nidogen-1 (Dziadek et al., 1995). 
 
Additional evidence for nidogen-1 production by mesenchymal cells was obtained in 
coculture experiments with rat mesenchymal peritubular and epithelial-like Sertoli cells 
(Konrad et al., 2000). Even though nidogen-1 was transcribed in peritubular cells and Sertoli 
cells, its mRNA was only translated by peritubular cells. Antibody perturbation experiments 
could further show that nidogen-1 is required for cell adhesion of peritubular cells. The fin-
ding that nidogen-1 is secreted by mesenchymal cells was also confirmed using a culture 
microecosystem of mammary epithelium where nidogen-1 is produced by mesenchymal cells 
but deposited between epithelial cells. Analysis of this in vitro system initially designed to 
investigate the role of nidogen-1 in gene regulation showed that nidogen-1 can regulate b-
casein expression in cooperation with laminin-1 (Pujuguet et al., 2000). 
 
The susceptibility of uncomplexed nidogen-1 to proteolytic degradation (Dziadek et 
al., 1988) allows speculation about such degradation playing a role during embryogenesis, 
where basement membrane assembly and degradation are tightly regulated (Dziadek, 1995). 
The growing knowledge about the action of matrix metalloproteases (Werb, 1997; Giannelli 
et al., 1997) will lead to a better understanding of the mechanisms behind this balance which 
is crucial for normal growth, morphogenesis and tissue repair. 
 
Nidogen-2 was recently isolated as osteonidogen or entactin-2 from an osteoblast-like 
cell line and shown to have 27.4% identity to nidogen-1 on the amino acid level (Kimura et 
al., 1998). Recombinant nidogen-2, a highly glycosylated 200kD protein, has a shape similar 
to nidogen-1. Electron microscopy shows that it also consists of three globular domains con-
nected by two threads although it is somewhat different in length (figure 1.4). Immuno-
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fluorescence and northern blots revealed coexpression and colocalisation of both nidogens in 
vessel walls and other basement membrane zones, but differences in heart and skeletal muscle 
(Kohfeldt et al., 1998). Nidogen-2 can bind to the nidogen-binding site g1III4 of the laminin 
g1 chain but with a 100 to 1000 fold lower affinity than nidogen-1 and interacts with a second 
binding-site of laminin-1 unrelated to the g1III4 module. Deletion of LE module 4 abolishes 
binding of both nidogens to the recombinant g1III3-5 fragment. In addition, nidogen-2 binds 
type IV and type I collagen and perlecan. However it does not interact with fibulin-1 or -2 like 
nidogen-1 (Kohfeldt et al., 1998). 
 
 
 
Figure 1.4: The domain organisation and modular structures of nidogen-1 and nidogen-2. Both nidogens 
comprise three globular domains. G1 and G2 are joined by a link region while G2 and G3 are connected by a 
rod-like structure. Different basement membrane proteins binding to G2 and G3 domain of nidogen-1 are in-
dicated. Legend: dark circles represent epidermal growth factor (EGF) like motifs, which are numbered in 
nidogen-1, dark boxes represent thyroglobulin (TG) like motifs and hexagons represent low density lipoprotein 
(LDL) receptor YWTD motifs (partially taken from Murshed, 2001). 
 
 
To understand the in vivo role of the nidogens in basement membranes, the mouse and 
worm model were studied. The lack of nidogen-1 in mice does not affect basement membrane 
formation, instead nidogen-1 -/- mice develop seizures and other neurological defects later in 
life (Murshed et al., 2000). This phenotype could be explained by the existence of the struc-
turally related nidogen-2/entactin-2 (Kohfeldt et al., 1998; Kimura et al., 1998) and a possible 
compensatory effect of nidogen-2 in basement membrane assembly of nidogen-1 deficient 
mice. Although immunostaining for nidogen-2 is stronger in distinct basement membranes, it 
does not appear to be transcriptionally upregulated in nidogen-1 -/- mice. Nidogen-2 null 
mutant mice also appear normal. The production of nidogen-1/-2 double null-mutant mice is 
currently underway (Smyth, personal communication). This will help to explain the import-
ance of nidogen-1 and -2 and their contribution to basement membrane stability. Recent 
results obtained from loss of function experiments in C. elegans support the neurological 
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phenotype found in nidogen-1 -/- mice. Introducing a stop codon into the homologous C. 
elegans nidogen gene causes irregular neuronal migration (Kim et al., 2000). Deletions in 
NID-1 however do not affect type IV collagen assembly into basement membranes (Kang and 
Kramer, 2000). 
 
 
1.3.3. Type IV Collagen 
 
The collagens are a glycoprotein family with at least 19 genetically distinct types 
(Prockop and Kivirikko, 1995) which can be divided into fibril-forming and non-fibrillar 
molecules. Typically, collagens consist of a ropelike superhelix comprising three polypeptide 
a chains wound round each other. These a chains contain a series of Gly-X-Y repeats. In 20-
22% of all triplets the positions X and Y are occupied by proline and hydroxyproline, re-
spectively. The non-fibrillar collagens can form three-dimensional networks (type IV), beaded 
filaments (type VI), anti-parallel dimers (type VII) or a hexagonal lattice (type VIII). 
 
7S NC1Triple Helix
NC1
7S NC1
 
 
Figure 1.5: Schematic representation of the type IV collagen network. Three a chains interact and form a triple 
helix with amino-terminal 7S and carboxy -terminal NC1 domains. Covalent interactions between four 7S and 
two NC1 domains and additional lateral interactions (not shown) result in a lattice which provides mechanical 
strength to the basement membrane (taken from Tunggal, 2000). 
 
 
Type IV collagen contains a carboxy-terminal noncollagenous domain (NC-1), a 
350nm long triple-helical domain and an amino-terminal 7S domain. It is only present in 
basement membranes, where it can self-assemble into a network via anti-parallel interactions 
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between the 7S domains of four molecules (Risteli et al., 1980; Glanville et al., 1985; 
Tsilibary and Charonis, 1986), the interaction of two molecules at their carboxy-terminal NC1 
domains and by lateral aggregation (Timpl et al., 1981; Yurchenco and Furthmayr, 1984). 
This network (figure 1.5) provides structural support to the basement membrane, facilitates 
assembly of laminin, nidogen-1/entactin-1 and perlecan (Laurie et al, 1986) and functions as a 
size-selective filter unit. 
 
Type IV collagen a chains are encoded by six genes, COL4A1-COL4A6 which are 
arranged in pairwise head-to-head organisation (Soininen et al., 1988; Mariyama et al., 1992; 
Zhou et al., 1994). Since bidirectional regulatory elements have been identified between each 
pair, coordinate transcription and expression of COL4A1-COL4A2, COL4A3-COL4A4 and 
COL4A5-COL4A6 was suggested. This assumption was confirmed by the finding that the 
most abundant type IV collagen with ubiquitous expression in basement membranes (Hudson 
et al., 1993) has the chain composition [a1(IV)]2a2 (IV). In addition, colocalisation of the a3 
and a4 chains (Kleppel et al., 1989; Miner and Sanes, 1994) as well as the a5 and a6 chains 
could be demonstrated, although the a5 chain is also expressed without the a6 chain in the 
glomerular basement membrane (Peissel et al., 1995). 
 
Mutations in the COL4A3, COL4A4 or COL4A5 gene result in a progressive heredi-
tary disease of the glomerular basement membrane, Alport's syndrome (Kashtan and Michael, 
1993). In Alport's patients  the basement membranes of the kidneys are disorganised and 
fragile and less resistant to the high hydrostatic pressure. Mouse models which either lack the 
a3(IV) chain (Cosgrove et al, 1996; Miner and Sanes, 1996) or both the a3(IV) and the 
a4(IV) chain undergo fibrosis leading to a glomerulonephrosis. This is possibly due to the 
failure in switching from a1, a2 expression to a3, a4 and a5 expression which occurs during 
glomerular development (Lu et al., 1999).  
 
 
1.3.4. Perlecan, a heparan sulphate proteoglycan 
 
Proteoglycans are very heterogenous in composition and are present in the extra-
cellular matrix, on cell surfaces (Bernfield et al., 1999) or in intracellular granules (Burditt et 
al., 1985). They consist of a protein core and glycosaminoglycan (GAG) chains (Prydz and 
Dalen, 2000). These long, unbranched, strongly anionic polysaccharide chains can bind 
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cations as well as H2O. Thereby hydrated GAG gels are able to resist pressure changes in 
tissues, a property that is particularly important for joint function. In vitro GAGs can bind 
growth factors, matrix components, enzymes, enzyme inhibitors and cell adhesion molecules. 
The core proteins themselves may show particular biological activities (Iozzo, 1998). Insights 
gained from in vivo studies in Drosophila and mice imply specific functions for heparan 
sulphate proteoglycans in cell differentiation and morphogenesis (Perrimon and Bernfield, 
2000). 
 
In mammals three proteoglycans are found in basement membranes: Perlecan 
(Murdoch et al.,1994), agrin (Groffen et al., 1998) and bamacan (Couchman et al., 1996). Per-
lecan, the most widespread and highly expressed proteoglycan of basement membranes and 
cartilage, comprises a 470kD core protein with a beads-on-a-string-like appearance and often 
carries three heparan sulphate side chains at its amino-terminal end (Costell et al., 1996; 
Groffen et al., 1996; Schulze et al., 1996; Friedrich et al., 1999). Domain III of its protein core 
interacts with cell surfaces (Chakravati et al., 1995, Peng et al., 1998; Hohenester et al., 1999; 
Talts et al., 1999) while domain IV binds nidogens, the laminin-1/nidogen-1 complex 
(Battaglia et al., 1992), type IV collagen (Laurie et al., 1986, Villar et al., 1999), fibronectin, 
fibulin-2, and heparin (Hopf et al., 1999). 
 
Perlecan occurs in preimplantation embryos prior to basement membrane formation 
(Dziadek et al., 1985; Smith et al., 1997) and inside the blastocyst on the outer surface of 
trophectoderm cells (Carson et al., 1993). Interestingly, the distribution pattern of perlecan is 
similar to that of fibroblast growth factor (FGF)-2 in various basement membranes of the 
mouse embryo (Friedl et al., 1997) which led to speculations about an involvement of per-
lecan in growth control (Klein et al., 1995; Weiser et al., 1997). Perlecan expression was also 
demonstrated on the surface of vascular endothelial cells, possibly concentrating thromo-
spondin 1 (Vischer et al., 1997), and in mesenchymal tissues like cartilage where it persists 
into adulthood (Handler et al., 1997). Mice lacking perlecan show defects in cartilage and 
cephalic development (Arikawa-Hirasawa et al., 1999) and while basement membranes form 
they become disrupted with increasing mechanical stress (Costell et al., 1999) which suggests 
a role of perlecan in regulating basement membrane integrity and permeability (Murdock et 
al., 1993; Gauer et al., 1996; Groffen et al., 1997; Groffen et al., 1999). 
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1.4. Basement membrane assembly and structure 
 
Although many different basement membrane components and numerous isoforms of 
these have been identified, our understanding how molecules become deposited, locally 
concentrated and organised into basement membranes after secretion is comparatively poor. 
In vitro experiments demonstrate that dermal fibroblasts can produce type IV collagen, 
perlecan and nidogen, but they need keratinocyte integrins to bind type IV collagen in order to 
initiate basement membrane formation (Fleischmajer et al., 1998). Keratinocytes are also 
necessary for relocalisation of nidogen, which is of dermal origin during early basement 
membrane formation of in vitro skin models (Fleischmajer et al., 1995). Retinal basement 
membrane instead seems to require collagens for reassembly of neuroepithelia (Halfter et al., 
2000) while alveolar epithelial cells can synthesise all major basement membrane components 
but still need exogenous laminin-1 for complete basement membrane assembly (Furuyama 
and Mochitate, 2000). 
 
 
 
 
 
Figure 1.6: Molecular model of the basement membrane based on in vitro  data (modified from Yurchenco and 
Schittny, 1990).The two major basement membrane networks are formed by laminin (blue) and type IV collagen 
(red) and are bridged by nidogen-1 (yellow). Perlecan (green) is a heparan sulphate proteoglycan which can 
interact with itself, type IV collagen and laminin. 
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Most of these studies on basement membrane formation are descriptive or in vitro 
experiments. In an in vivo approach the deletion of nidogen-binding module g1III4 interferes 
with the formation of the laminin-1/nidogen-1 complex (Mayer et al., 1998). Although 
embryonic stem cells homozygous for this defect secrete mutant laminin-1 which fails to 
associate with nidogen-1, they are still able to form embryoid bodies with a differentiation 
pattern similar to wild type. However complex the mechanisms of basement membrane 
formation might be, the self assembly of laminin and type IV collagen (described above) are 
still considered the main principles of basement membrane formation and the proposed 
function of nidogen-1 as the linker module between the type IV collagen and laminin 
networks has dominated the model of basement membrane structure (Aumailley et al., 1989; 
figure 1.6). 
 
 
 
1.5. Embryoid bodies 
 
Embryoid bodies are cellular aggregates derived from either embryonic stem cells or 
embryonic carcinoma cells (Martin, 1980), which resemble early stages of mouse develop-
ment (figure 1.7). The pluripotent F9 cells (Bernstine et al., 1973; Alonso et al., 1991) have a 
limited differentiation repertoire forming endoderm-like structures which develop only upon 
treatment with e.g. retinoic acid (Strickland and Mahdavi, 1978) or dibutyryl cyclic AMP 
(cAMP; Hogan et al., 1983). In F9 derived embryoid bodies treated with retinoic acid cells are 
found on the outer surface which are morphologically similar to visceral endoderm while F9 
monolayers treated with retinoic acid and dibutyryl cAMP instead differentiate into parietal 
endoderm (Strickland et al., 1980; Damjanov et al., 1994). Parietal and visceral endoderm are 
two distinct populations of extra-embryonic endoderm found in the normal mouse embryo 
shortly after implantation (Hogan et al., 1994). 
 
Since embryonic carcinoma cell lines can participate in the formation of chimeric 
mice, they were an important tool for the first gene transfer experiments in mouse before it 
was possible to establish totipotent embryonic stem cell lines in vitro (Martin et al., 1980). 
Today embryoid bodies grown from F9 cells represent a well studied in vitro system of early 
mouse embryogenesis which can help to understand the nature of endodermal and epithelial 
differentiation (Coucouvanis and Martin, 1995). For example, it has been shown that Indian 
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hedgehog, which is upregulated during extra-embryonic endoderm differentiation in F9 
embryoid bodies is also increased in 6.5 day old mouse embryos (Becker et al., 1997). 
Similarly, a-Fetoprotein is synthesised by visceral endoderm (Hogan et al., 1981; Grover et 
al., 1983) in F9 embryoid bodies and it is restricted to the visceral endoderm during post-
implantation development in mouse (Dziadek and Adamson, 1978). Differentiation of F9 cells 
into parietal or visceral endoderm upon treatment with retinoic acid and cAMP or retinoic 
acid alone, respectively, is accompanied by increasing synthesis of basement membrane 
proteins. At the transcriptional level a coordinate increase of the laminin a1, b1 and g1 chains 
and the type IV collagen a1 chain (Durkin et al., 1986; Kleinman et al., 1987) has been 
demonstrated, whereas at the protein level the synthesis of the laminin b1 and g1 chains is 
first induced followed by the a1 chain of type IV collagen and a-fetoprotein (Rogers et al., 
1990). Analysis of the gene regulation of the b1 and g1 chains revealed that both contain 
DNA regulatory elements which are activated during F9 induction (Chang et al., 1996; Li and 
Gudas, 1996). Differentiation into visceral or parietal endoderm leads to a 5-10 fold and 15-
20 fold increase in the synthesis of basement membrane proteins (Howe and Solter, 1980; 
Prehm et al., 1982; Cooper et al., 1983) and in parietal endoderm the production of laminin 
and nidogen-1 occurs independently. Laminin and nidogen-1 are secreted to the medium and 
deposited at the cell surface and at cell junctions (Carlin et al., 1983; Chung et al., 1993). 
 
 
Figure 1.7: Embryoid bodies undergo differentiation processes analogous to early mouse development. On the 
left a saggital section through a mouse embryo at embryonic day 6.0, when the proamniotic cavity has been 
formed, is depicted. To the right a cross section (dashed line) through the egg cylinder is shown and compared to 
an embryoid body after cavitation. (modified from Coucouvanis and Martin, 1995). 
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1.6. Aim of the present study 
 
The purpose of this study was to analyse the importance of the laminin/nidogen-1 
interaction for proper basement membrane formation and stability. The contribution of 
nidogen-2 to stabilisation of major basement membrane networks is not clear at the moment. 
 
Based on the basement membrane model designed by Yurchenco and Schittny (1990) 
nidogen-1 links the laminin lattice to the type IV collagen network. In order to test this 
hypothesis, I planned to disturb the laminin/nidogen-1 interaction by introducing an excess of 
recombinantly expressed nidogen-binding sites. In theory these additional binding-sites 
should compete with intrinsic laminin molecules presenting their binding-sites to nidogen 
molecules. 
 
For time-specific interference with the laminin/nidogen-1 interaction at different 
stages of basement membrane development inducible expression systems such as the 
ecdysone-inducible (Invitrogen) or the retroviral tet on/off system (Hofmann et al., 1996) 
could be applied. It was also decided to use the EF1a promotor for constant protein 
expression which was previously shown to work well in F9 cells (Niimi and Kitagawa, 
1997b). F9 and D3 (Evans and Kaufman, 1981) cells were chosen as they represent an in vitro 
system of basement membrane formation very similar to early stages of mouse development 
where the basement membrane separates the inner ectodermal cell mass from the outer 
endodermal epithelium. To rule out that any phenotype might be caused by artefacts due to 
clonal selection of overexpressing cells, the laminin g1III3-5 FLAG fusion protein was also 
added extraneously to developing wild type embryoid bodies. This required the nidogen-
binding site to be expressed in 293-EBNA cells using the CMV promotor, affinity-purified 
and added to differentiating embryoid bodies derived from wild type F9 cells. For analysis of 
basement membrane formation and stability molecular biological, biochemical, microscopi-
cal, and physiological techniques were used and the expression of markers for cell differen-
tiation were determined in the embryoid bodies. 
 
 
 
 
 
 
 
 
19
2. Results 
 
2.1. Cloning of nidogen-binding site constructs and controls 
 
All constructs (figure 2.1) were derived by PCR from full-length mouse laminin g1 
cDNA which was obtained by reverse transcription of mouse kidney total RNA. Considering 
the complex secondary structure of LE 4, which contains the nidogen-binding site, it was 
expressed together with its neighbouring LE modules 3 and 5 (amino acid position 771-932). 
Previous work had shown that such a polypeptide folds correctly (Stetefeld et al., 1996) and 
binds to nidogen-1 in a similar manner to native laminin (Mayer et al., 1993). For control 
purposes, the construct g1III3-5mut with the point mutation N802S in LE 4, which decreases 
binding affinity for nidogen-1 by 46,000 fold (Poeschl et al., 1996) and the construct g1V1-3 
containing the LE modules 1-3 (amino acid position 340-492) of domain V of the g1 chain 
were also expressed. To enable secretion of the expressed proteins to the extracellular space 
and their detection and purification, sequences encoding the the BM40 signal peptide and 
FLAG tag (Hopp et al., 1988), respectively, were added to the N-terminus of the polypeptides. 
 
 
Figure 2.1: Production of nidogen-binding site constructs and controls: The site for interaction between laminin-
1 and nidogen-1 has been localised to LE module 4 of domain III of the laminin g1 chain (Mayer et al., 1993). 
Three different FLAG fusion proteins ( ) were constructed and modified with the BM40 signal peptide to 
ensure secretion to the extracellular space, g1III3-5 coding for LE modules 3-5, g1III3-5mut which differs from 
g1III3-5 in a point mutation of amino acid 802 from N to S a mutation causing a 46000 fold loss of nidogen 
binding activity (Poeschl et al., 1996) and g1V1-3 comprising 3 LE modules of domain V. 
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Although LE modules 3-5 had earlier been cloned into pCEP-Pu (Kohfeldt et al., 
1997) which added the BM40 signal peptide, to insert the FLAG sequence the LE 3-5 coding 
sequence had to be subcloned into NheI/NotI restricted CMV-NFlag (a pCEP-Pu based vector 
with the FLAG tag placed 3 prime to the BM40 signal peptide sequence). To obtain LE 
modules 1-3 a PCR was performed on the g1 cDNA using the sense primer AAT TGC TAG 
CCC TTC CTT GTG ACT GCA ATG GC and the antisense primer AAT AGC GGC CGC 
CTA GGG TGT GCA GCC CTT AGG containing a NheI and NotI site, respectively. After 
digestion the PCR product was cloned into the restriction digested CMV-NFlag plasmid. To 
mutate amino acid 802 in g1III3-5 from an asparagine to a serine, the sequence for the FLAG 
tagged LE modules 3-5 was subcloned into pBluescript KS (+) by HindIII/XhoI digestion. 
Then site-directed mutagenesis was performed using the TransformerÔ Site-Directed Muta-
genesis Kit (Clontech Laboratories Inc.) following the manufacturer's instructions with 
TransSCA (5' GTG ACT GGT GAG GCC TCA ACC AAG TC 3') as the selection primer 
and the primer N802S (5' GTG TAA CGA CAA TAT TGA CCC CAG CGC GGT TGG C 3') 
as the mutagenic primer. Constructs were verified by DNA sequencing and correspond to g1 
sequences available in the SWISS-PROT data base (primary accession number P02468). 
 
 
 
Figure 2.2: Restriction digest on nidogen-binding site constructs and controls cloned into pBKEF-5 (A) and 
pCEP-Pu (B). A) HindIII/NotI restriction of the empty pBKEF-5 expression vector yields two fragments of 
4.0kb and 1.4kb separated on 0.7% agarose gel. Upon insertion of the nidogen-binding site constructs g1III3-5, 
g1III3-5mut and the control region g1V1-3 an additional 0.6kb band appears. Lane g1 III3-5mut is derived from a 
later experiment. B) HindIII/NheI restriction of g1III3-5 cloned into pCEP-Pu excises the BM40 signal peptide 
while a slightly shifted fragment coding for the BM40 signal peptide plus the FLAG tag is obtained from g1III3-
5 inserted into CMV-NFlag. Restriction digests were separated on a 1.5% agarose gel and for better comparison 
the fragments of interest are marked with white dots. 
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The DNA coding for g1III3-5mut, g1III3-5 and g1V1-3 were excised with 
HindIII/XhoI from pBluescript KS (+) or CMV-NFlag respectively and inserted into pBKEF-
5 linearised with HindIII/SalI. This vector is a fusion plasmid formed of pBK-CMV and pEF 
BOS (Mizushima and Nagata; 1990) and contains the EF1a promotor which drives protein 
expression in F9 cells. For expression of the nidogen-1 binding site in 293-EBNA cells 
(Smyth et al., 2000) g1III3-5 cloned into CMV-NFlag was used (figure 2.2). 
 
The constructs described above were expected to lead to constitutive protein ex-
pression. For inducible expression with the mammalian ecdysone-inducible system (Invitro-
gen) and the retroviral tet on/off system (Hofmann et al., 1996), g1III3-5 was also cloned into 
the expression vectors pIND and pGEM-IRES respectively. To test the ecdysone system, F9 
cells were transfected with pINDg1III3-5 and pVgRXR, the transactivator encoding plasmid. 
Resistant F9 cells were grown either under differentiating or non-differentiating conditions 
and protein expression induced with muristerone A, a synthetic analog of the steroid hormone 
ecdysone. Cell supernatants and extracts were tested for g1III3-5 expression by immuno-
blotting but no recombinant protein was detected. Cloning of the g1III3-5 construct into 
pGEM-IRES was stopped when control infections with pGEM-IRES lacZ containing viruses 
showed extremely low efficiency (results not shown). 
 
 
 
2.2. g1III3-5 expression in 293-EBNA cells 
 
293-EBNA cells were electroporated with g1III3-5 CMV-NFlag, selected for 
puromycin resistance and grown to confluency. Serum-free supernatant was collected, TCA 
precipitated and tested for expression of the recombinant protein. Polyacrylamide gel 
electrophoresis showed that the fusion protein was expressed without degradation (figure 2.3). 
Immunoblotting with the anti-FLAG Bio M2 antibody on the reduced supernatant of trans-
fected 293-EBNA cells identified a single, 25kD band of a FLAG tagged protein. Cells ex-
pressing the g1III3-5 construct were grown in large scale and 500ml supernatant was collected 
for affinity purification. The supernatant was centrifuged and after overnight dialysis into 
TBS, pH 7.4 was loaded on to a anti-FLAG M2 agarose affinity column. The column was 
washed four times with TBS, pH 7.4 to remove unspecifically bound proteins and the FLAG 
tagged protein was eluted with 100µg/ml FLAG peptide. 
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Figure 2.3: Expression of g1III3-5 in 293-EBNA cells. A) Coomassie staining of a 15% polyacrylamide gel 
loaded with reduced supernatants from transfected and untransfected cells reveals an additional band of about 
25kD in the medium of resistant cells while no recombinant protein is found in the cell extracts. All lanes are 
excised from one gel. B) Western blot analysis with the anti-FLAG Bio M2 antibody under reducing conditions 
identifies a FLAG tagged protein of 25kD in the supernatant of transfected cells. Representative lanes are 
derived from one experiment. 
 
 
 
Figure 2.4: Affinity purification of recombinantly expressed nidogen-binding site construct g1III3-5. Collected 
supernatants from untransfected (control) and transfected cells, flow-through and wash fractions were TCA 
precipitated and separated on a 15% polyacrylamide gel after addition of 5% ß-mercaptoethanol. The gel elution 
is documented with 1/50 of each fraction. Lanes are derived from two gels. 
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Comparison of the flow-through with the supernatant loaded onto the column showed 
that not all protein bound to the affinity matrix (figure 2.4). Therefore the purification was 
repeated after regeneration of the anti-FLAG M2 agarose gel. In total 400µg protein could be 
purified from 500ml of cell supernatant. Before use in cell culture experiments the protein 
was dialysed against unsupplemented DMEM F9 growth medium. 
 
 
 
2.3. Expression of g1III3-5, g1III3-5mut and g1V1-3 in F9 and D3 cells 
 
F9 cells were electroporated with the FLAG fusion constructs g1III3-5, g1III3-5mut 
and g1V1-3 and selected for resistance with G418. A total of 25 clones per construct were 
picked and expanded. Expressing clones (six for g1III3-5, nine for g1III3-5mut and four 
expressing g1V1-3) were identified by immunoblotting with the Bio M2 monoclonal antibody 
against the FLAG epitope. For comparison of the levels of protein expression in these cell 
clones, loading was standardised with the detection of BM40, a calcium binding extracellular 
matrix protein (Nischt et al., 1991), also produced by undifferentiating F9 cells (figure 2.5). 
 
 
 
Figure 2.5: Levels of exogenous protein expression: Western blot analysis on supernatants of stably transfected 
F9 teratocarcinoma cells with a mouse monoclonal antibody detecting the FLAG tag, shows approximately equal 
expression of all three constructs, g1III3-5, g1III3-5mut and g1V1-3. In case of the g1III3-5mut construct g1III3-
5mut/B cells were choosen for further studies. As a control F9 cells carrying the empty expression vector were 
analysed. For normalisation of loading a rabbit polyclonal antibody against the mouse BM40 protein was used. 
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Electroporation of the embryonic stem cell line D3 with the same constructs used for the 
transfection of F9 cells gave many G418 resistant clones, but none expressed the FLAG 
tagged recombinant proteins (results not shown). 
 
 
 
2.4. Comparison of embryoid body phenotype in two different cell culture systems 
 
Two systems, the hanging drop method and the cell spin system have been established 
as embryoid body culture techniques. However direct comparison, especially for the pro-
duction of F9 derived embryoid bodies has not been carried out. To test which one was the 
most appropriate, F9 cells which carry the empty expression vector and are G418 resistant, 
were cultured as embryoid bodies in both systems. These cells are designated the control 
clone below. 
 
The drop method uses 20µl of a cell suspension containing 1.5x105 cells/ml hanging 
on an inverted petri-dish. After two days in culture each drop contained a small aggregate of 
cells which were released from the drops and kept in suspension cultures of 10ml in a bac-
terial petri-dish until harvest. During this period, medium was changed every second day. 
The cell spin system in contrast started with a density of 1.2x105 cells/ml. 100ml of 
this cell suspension was maintained in siliconated glass bottles overnight under continuous 
gentle stirring. The next day when small aggregates had formed, 200ml of fresh medium was 
added and thereafter changed daily. 
 
The control clone appeared to grow equally well in both systems (data not shown) and 
embryoid body morphology showed similar results. In both systems, bright central areas indi-
cative of cavity formation could be observed (figure 2.6A). 
 
To analyse the expression of basement membrane components induced by retinoic 
acid in both systems, total homogenates were prepared from differentiated control embryoid 
bodies after 12 days culture. Polyacrylamide gel electrophoresis of these homogenates and 
analysis for laminin-1 and nidogen-1 by immunoblotting was performed with a rabbit 
polyclonal antibody raised against laminin-1/nidogen-1 complexes isolated from the EHS 
tumor. Bands were seen for the b1 (220kD) and g1 (210kD) chains of laminin-1 as well as 
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nidogen-1 (150kD) with similar expression levels for all three proteins in both systems. No 
band corresponding to the a1 laminin chain (400kD) was seen (figure 2.6B). Basement mem-
brane structure was analysed by immunohistochemistry on embryoid body cryosections with 
the same antibody (figure 2.6C). This revealed continuous stretches of laminin and nidogen-1 
present directly basal to the most peripheral cells in the embryoid body. These signals were 
interpreted as intact basement membranes and occurred in both systems. 
 
 
 
Figure 2.6: Comparison of embryoid bodies formed by the hanging drop technique or in the cell spin system. F9 
cells carrying the empty expression vector represent the control clone and were raised for 12 days with both 
methods in culture with retinoic acid. Analysis by transmission light microscopy is shown in representative 
images in A (Bar = 100µm). Immunoblotting for laminin-1 and nidogen-1 with a rabbit polyclonal antibody on 
total homogenates prepared from 12 day old embryoid bodies and standardisation with a mouse monoclonal 
antibody directed against actin are depicted in B. C shows immunohistochemical localisation of laminin-1 in 
cryosections of 12 day old cell aggregates (Bar = 100µm). In D similar cryosections were stained for TROMA-1. 
(Bar = 50µm). 
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To determine if retinoic acid induced epithelial differentiation into visceral endoderm, 
control embryoid bodies raised in the two systems were compared by staining with TROMA-
1 antibodies. These are directed against the intermediate filament component Endo A 
(cytokeratin 8) which is produced by endodermal cells in the mouse embryo. It stained cells 
primarily at the embryoid body periphery in both cultures (figure 2.6D) which indicates the 
expected differentiation into the visceral endoderm. 
 
The experiments performed to compare the two embryoid body culture systems 
suggested similar growth and differentiation in both. The only obvious difference at the end of 
culture was in the yield of embryoid bodies which was approximately 100 fold higher in the 
spinner flask than in the petri-dish for comparable amounts of labour. However, the cell spin 
system is expensive to run requiring a high throughput of media and needing specialised 
equipment as well as occupying much incubator space. Thus initially the hanging drop 
method was used to set up embryoid body cultures from the F9 cell lines expressing the 
laminin g1 derived peptides. However, when the increase in embryoid body diameter was 
measured during twelve days of culture it became apparent that the embryoid bodies 
expressing the recombinant polypeptides were smaller in size than those formed by the con-
trol clone. This observation is documented for the F9 cell lines carrying the g1V1-3 and 
g1III3-5/B construct and the control in figure 2.7. 
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Figure 2.7: Comparison of growth rates of F9 derived embryoid bodies from two different cell culture systems. 
Diameters of embryoid bodies grown from clones expressing the constructs g1III3-5/B and g1V1-3 and from a 
control clone carrying the empty expression vector were measured. Mean values were calculated and are de-
picted in the graph. 
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Assuming that recombinant expression might put pressure on the cell metabolism, 
resulting in growth retardation, providing an improved nutrition and oxygen supply to the 
developing embryoid body might overcome this problem. Therefore control, clone g1V1-3 
and g1III3-5/B embryoid bodies were test-cultured in the spinner flask system and here 
showed a far more similar growth rate than in the petri-dish (figure 2.7). Daily exchange of 
medium combined with continuous agitation apparently could compensate for metabolic 
pressure caused by recombinant expression. Therefore it was decided to use the cell spin 
system for further experiments to ensure that possible phenotypes are specific to recombinant 
expression of the laminin g1 constructs and are not cell culture dependent. 
 
 
 
2.5. Comparison of F9 embryoid bodies expressing the laminin g1 constructs 
 
2.5.1. Analysis of embryoid body growth rate and morphology 
 
Growth rates were determined every second day for the various F9 cell clones cultured 
in the cell spin system (figure 2.8). All of them grew at similar rates in the spinner flask until 
day 8. However embryoid bodies formed by the control showed an obvious divergence in size 
which ranged from 800 to 1000µm at day 12. 
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Figure 2.8: Comparison of growth rates of F9 derived embryoid bodies g1III3-5/A, g1III3-5/B, g1III3-5mut and 
g1V1-3. F9 cell clones stably expressing g1III3-5, g1III3-5mut and g1V1-3 were grown in the cell spin system 
and differentiated with 5x10-8M retinoic acid. The control represents F9 cells transfected with the empty 
expression vector. 
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Staining of these embryoid bodies with Lucifer Yellow VS, a necrosis specific marker 
and SYTOX, a fluorescent dye which stains single dead cells in intact tissue showed that the 
dark central regions observed by light microscopy in g1III3-5/A and g1III3-5/B expressing 
clones were areas of necrosis (figure 2.9). Both clones expressing the nidogen-binding site de-
veloped larger necrotic areas than g1V1-3 expressing embryoid bodies. Where the embryoid 
bodies expressed the mutated nidogen-binding site they were morphologically similar to the 
control clone which does not express any recombinant protein. SYTOX staining could be ob-
served in the periphery of all clones, particularly in the control clone and g1III3-5mut which 
showed strong SYTOX signals in regions of low or no Lucifer Yellow VS staining, indicating 
programmed cell death, possibly an effect induced by differentiation. 
 
 
 
Figure 2.9: LYVS and SYTOX staining on differentiated, F9 embryoid bodies expressing the laminin g1 FLAG 
fusions g1III3-5, g1III3-5mut and g1V1-3. Viability of differentiated embryoid bodies was assessed by 
transmission light microscopy (lower panel), Lucifer Yellow VS staining (LYVS; upper panel) shows strongest 
staining in the inner core of clone g1III3-5/A and g1III3-5/B. SYTOX staining (middle panel) also gives strong 
signals in the inner core of g1III3-5/A and in peripheral areas of g1III3-5/B, g1III3-5mut and the control clone 
(Bars = 100µm). 
 
Total RNA was isolated for the analysis of nidogen-1 mRNA levels, to exclude the 
possibility that nidogen-1 expression in the embryoid bodies could be effected by the trans-
fection procedure and/or recombinant expression of the various polypeptides. However, levels 
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of expression of nidogen-1 mRNA were similar in all clones irrespective of which construct 
they contained. Equivalent loading was tested by subsequent probing of the blot with GAPDH 
(figure 2.10). 
 
 
 
Figure 2.10: Expression of FLAG fusion proteins does not affect nidogen-1 mRNA level: Total mRNA was 
prepared from 12d old retinoic acid-treated embryoid bodies, separated on a 1% agarose gel and hybridised with 
a cDNA probe for nidogen-1. Probing for GAPDH message showed that comparable amounts of total mRNA 
had been loaded. 
 
 
2.5.2. Detection of basement membrane proteins in g1III3-5/A, g1III3-5/B, g1III3-5mut 
and g1V1-3 expressing embryoid bodies 
 
To see if differentiation with 5x10-8M retinoic acid induced the expected production of 
basement membrane components total homogenates were prepared from the various 12 day 
old embryoid bodies. After separation on a 3-10% polyacrylamide gradient gel and 
subsequent transfer to a nitrocellulose membrane, protein extracts were tested for laminin-1 
and nidogen-1 (figure 2.11). This revealed similar nidogen-1 levels in g1V1-3, g1III3-5/A, 
g1III3-5/B, g1III3-5mut and the control clone. This was surprising since one possible con-
sequence of blocking the binding of nidogen-1 to the laminin network by expression of the 
nidogen-binding site could be the loss of free nidogen-1 from the embryoid body and its 
release into the cell culture medium. Further attempts to detect nidogen-1 in the growth 
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medium by radioactive labeling with 3H-leucine failed. Unlike the levels of nidogen-1, levels 
of laminin-1 varied markedly between the clones. The homogenates prepared from g1V1-3, 
g1III3-5/A and B and that expressing the g1III3-5mutant all appeared to contain greater 
amounts of laminin b1 and g1 chains than those of the control (nonexpressing) clone. 
 
 
 
 
Figure 2.11: Immunoblot for laminin-1 and nidogen-1 on embryoid body total homogenates. A rabbit polyclonal 
antibody against laminin-1 and nidogen-1 was used to detect these proteins in total homogenates prepared from 
12d old retinoic acid-treated embryoid bodies. Coomassie staining of the membrane shows that equal amounts 
had been loaded and transferred to the nitrocellulose. Blot 1 and 2 compare homogenates prepared from two 
different spinner cultures. Control describes embryoid bodies carrying the empty expression vector, g1III3-5/A 
and g1III3-5/B represent two different clones from a single transfection with the g1III3-5 construct. Embryoid 
bodies designated g1V1-3 and g1III3-5mut result from F9 clones stably expressing constructs of the same 
designation. 
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Since these differences may be due to changes in basement membrane assembly, its 
structure was analysed by immunohistochemistry on embryoid body cryosections with a 
rabbit polyclonal antibody against laminin-1. This revealed regions of continuous laminin-1 
signal at the periphery of control, g1V1-3 and g1III3-5mut expressing embryoid bodies, while 
in g1III3-5/A and g1III3-5/B laminin-1 signals have a highly disrupted appearance (figure 
2.12). Double staining for laminin-1 and nidogen-1 using a monoclonal antibody reacting 
with the G2 domain of mouse nidogen-1 (figure 2.13) revealed complete colocalisation of 
both proteins in g1III3-5mut, g1V1-3 and control embryoid bodies, while embryoid bodies 
g1III3-5/A and g1III3-5/B derived from the nidogen-binding site expressing cells showed im-
perfect colocalisation with some laminin not occurring together with nidogen-1. 
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Figure 2.12: Immunohistochemical localisation of laminin-1 in 12d old F9 cell derived embryoid bodies: Cells 
stably expressing the constructs g1III3-5, g1III3-5mut and g1V1-3 were differentiated into embryoid bodies with 
5x10-8 M retinoic acid, cryosectioned and stained for laminin-1. As a control F9 cells carrying the empty ex-
pression vector were used. g1III3-5/A and g1III3-5/B represent two different clones from one transfection with 
the g1III3-5 construct. Note the pronounced cavitation seen in control embryoid bodies and, particularly, in those 
derived from the clone g1III3-5mut. Bar = 100µm. 
 
33
 
Figure 2.13: Double immunofluorescence for laminin-1 and nidogen-1. Cryosections of differentiated 12d old 
embryoid bodies were incubated simultaneously with a rabbit polyclonal antibody against laminin-1 (green) and 
a rat monoclonal antibody against nidogen-1 (red). F9 cells carrying the empty expression vector were used as a 
control. g1III3-5/A and g1III3-5/B represent two different clones from a single transfection with the g1III3-5 
construct. Embryoid bodies described as g1V1-3 and g1III3-5mut result from F9 clones stably expressing con-
structs carrying the same designation. Bar = 50µm. 
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Attempts to show if the FLAG fusion proteins colocalised with laminin-1 staining in 
the F9 derived embryoid bodies using a biotinylated mouse anti-FLAG monoclonal failed in 
both cryosections and whole mount embryoid bodies (results not shown). 
 
 
2.5.3. Differentiation and permeability properties of F9 embryoid bodies expressing 
g1III3-5, g1III3-5mut and g1V1-3 
 
Embryoid body differentiation was studied morphologically using semithin sections. 
Embryoid bodies were fixed, dehydrated and embedded in araldite. After polymerisation, 
1µm sections were prepared and stained with methyl blue. Transmission light microscopy of 
these sections revealed no striking morphological differences between any of the clones 
(figure 2.14) despite distinct changes in basement membrane formation (figure 2.13). All 
embryoid bodies showed a differentiated external cell layer often displaying microvilli, a mor-
phological marker of endodermal differentiation (figure 2.14, lower panel, 2x magnification). 
 
Epithelial differentiation was studied using the TROMA-1 monoclonal antibody 
directed against mouse cytokeratin 8. Both the control clone and g1V1-3 expressing embryoid 
bodies showed strong staining in the flat surface cell layer. However, in embryoid bodies 
expressing the nidogen-binding site, TROMA-1 signals were seen occuring widely over the 
embryoid body and not merely restricted to the outer cells (figure 2.15). While TROMA-1 
positive cells were occasionally present internally in control embryoid bodies and those 
derived from the g1III3-5mut and g1V1-3 expressing cells, these were far rarer. While certain 
cells appear to show markers for endodermal development in embryoid bodies with a disrup-
ted basement membrane, these are expressed in abnormal localities. 
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Figure 2.14: Semithin sections of F9 cell derived embryoid bodies. Embryoid bodies expressing the laminin g1 
FLAG fusions g1III3-5, g1III3-5mut and g1V1-3 were maintained in the cell spin system supplemented with 
retinoic acid for differentiation. After 12 days of culture they were harvested for the preparation of semithin 
sections. After staining these were analysed by transmission light microscopy and representative images are 
shown in upper panel (bar = 100µm) . Zoomed pictures depicted in the lower panel (bar = 50µm) correspond to 
image areas surrounded by boxes in the upper panel. Arrows point to microvilli. 
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Figure 2.15: Immunofluorescence for TROMA-1: Cryosections of differentiated 12d old embryoid bodies 
derived from control, g1V1-3, g1III3-5/A and g1III3-5/B and g1III3-5mut expressing F9 cells were stained with a 
rat monoclonal antibody against TROMA-1 (Kemler et al., 1981). Bar = 50µm. 
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The expression of PECAM-1 (Tang and Honn, 1995), the platelet/endothelial cell 
adhesion molecule-1, was studied to provide a more comprehensive analysis of differen-
tiation. PECAM-1 is frequently used as a marker for vascularisation in embryonic stem cell 
derived embryoid bodies as it is concentrated along the borders between endothelial cells. F9 
cells have a lower differentiation potential and embryoid bodies derived from them do not 
vascularize as extensively as those derived from embryonic stem cells. For four clones, those 
expressing the g1V1-3 or g1III3-5 polypeptides and the control, a similar pattern of staining 
was observed with a marked increase between days 10 and 12. However, the clone derived 
from g1III3-5mut had a generally far higher PECAM-1 staining, perhaps due to its altered 
morphology (figure 2.16). 
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Figure 2.16: PECAM-1 signal intensities during 12 days of F9 embryoid body culture treated with 5x10-8M 
retinoic acid. Whole mount stainings using a rat monoclonal antibody against mouse PECAM-1 were performed 
with embryoid bodies expressing the constructs g1III3-5/A, g1III3-5/B, g1III3-5mut and g1V1-3. F9 cells 
carrying the empty expression vector were included as a control. Representative images of 12 day old embryoid 
bodies are shown in A (bar = 100µm). The percentage of total area stained was calculated for all embryoid 
bodies by measuring PECAM-1 signals above a common treshold level. Average signal intensities during day 12 
days of culture are summarised in B. 
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Other differentiation markers for neuronal, skeletal and muscular cell types were 
tested. However, anti-NF200 and anti-myosin did not give any signal in differentiated F9 
embryoid bodies, possibly due to the limited differentiation repertoire of these. 
 
To determine if expression of the nidogen-binding site affects the function of 
basement membranes as permeability barriers (Williams, 1994) polymer diffusion into the 
embryoid bodies was studied. 
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Figure 2.17: Comparison of diffusion coefficients obtained from incubation of differentiated F9 cell derived 
embryoid bodies with rhodamine-labeled dextrans of 10kD and 70kD size. A) Embryoid bodies stably 
expressing the constructs g1III3-5, g1III3-5mut, g1V1-3 and a control clone were incubated with 10µM dextrans 
of either size. g1III3-5/A and g1III3-5/B represent two different clones from a single transfection with the g1III3-
5 construct. Fluorescence intensities were measured inside the embryoid bodies after 5min of diffusion. Mean 
diffusion coefficients + SD of ³6 traces of individual embryoid bodies were calculated. Two independent 
experiments were performed with comparable results. In B representative curves of single embryoid bodies 
(control and g1III3-5/A) incubated with 10kD and 70kD fluorescent dextrans are shown. 
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Kidney glomerular basement membranes are critical in the restriction of the passage of serum 
proteins into the urine, allowing the passage only of those with a molecular weight below 
70kD. Therefore embryoid bodies expressing the various polypeptides were washed and 
maintained in the physiological E1 solution (see Materials and Methods). Rhodamine-labelled 
dextrans of 10kD and 70kD were added to the embryoid bodies at a concentration of 10µM. 
Diffusion of the fluorescent molecules into the embryoid body was compared after 5min by 
analysis of serial optical sections with the laser scanning microscope. These sections were of 
distinct fluorescence intensity at different planes from the embryoid body`s surface to its 
center and dependent on the distance of diffusion of the rhodamine-labeled dextrans. 
Subsequent calculation of the diffusion coefficients (see Materials and Methods) showed for 
control embryoid bodies and g1V1-3 expressing embryoid bodies relatively low permeability 
for 10kD and 70kD dextrans compared to both clones expressing the nidogen-binding site, 
g1III3-5/A and g1III3-5/B (figure 2.17). Clone g1III3-5mut which expresses a mutated version 
of the nidogen-binding site demonstrates a diffusion behavior similar to clone g1III3-5. 
However differences in its morphology (see figure 2.12) made a direct comparison unreliable. 
 
 
 
2.6. Addition of affinity-purified laminin g1 FLAG fusion protein g1III3-5 to wild type 
embryoid bodies 
 
Artefacts due to the recombinant expression, genetic manipulation, or cloning could 
not be excluded as the causes of these differences upon expression of the nidogen-binding 
site. Therefore, the affinity-purified laminin g1 FLAG fusion protein g1III3-5, expressed in 
293-EBNA cells (section 2.2.) was added to the medium of wild type embryoid bodies. F9 
cells were maintained with retinoic acid in a spinner flask for two days and then transferred 
into single wells of a 96-well plate, and were grown further in the presence of the affinity-
purified laminin g1 FLAG fusion protein at a concentration of 10µg/ml. Nonsupplemented 
controls were also cultured. Both supplemented and nonsupplemented embryoid bodies grew 
in a similar manner to those in the spinner flask (figure 2.18). 
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Figure 2.18: Comparison of growth of F9 wild type embryoid bodies in the cell spin system and 96-well plates. 
Diameters of  embryoid bodies either differentiated in the cell spin system or in 96-well plates with 5x10-8M 
retinoic acid were measured at day two and eight of culture. The graph summarises growth data of three sets of 
embryoid bodies: wild type embryoid bodies cultivated in the spinner flask (cell spin system) and wild type 
embryoid bodies cultivated in the spinner flask for two days and then transferred into single wells either with 
(with FLAG g1III3-5) or without (without FLAG g1III3-5) addition of affinity-purified FLAG tagged g1III3-5. 
 
After 8 days of culture whole mount stainings for laminin-1 were performed and revealed in 
wild type embryoid bodies a network-like laminin-1 staining, whereas embryoid bodies 
treated with exogenous g1III3-5 FLAG fusion protein showed a highly disrupted laminin-1 
signal (figure 2.19). 
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Figure 2.19: Laminin-1 localisation in F9 wild type embryoid bodies treated with the FLAG fusion protein 
g1III3-5. Embryoid bodies were transferred from a spinner culture system into single wells at day two and then 
either supplied with additional FLAG fusion protein g1III3-5 at a concentration of 10µg/ml (A) or not (B). At 
day 8 of culture whole mount stainings with a rabbit polyclonal antiserum against laminin-1 were performed. 
Representative images show either the embryoid body top (upper panel; bar = 100µm) or part of a section 
through the embryoid body periphery (lower panel; bar = 25µm). 
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3. Discussion 
 
3.1. Establishment of cells expressing laminin g1 FLAG fusion proteins 
 
3.1.1. Cloning of the constructs 
 
The aim of this study was to discover if disruption of the laminin/nidogen-1 complex 
influences basement membrane formation and, if so, to analyse the consequences for cellular 
differentiation. To interfere with the laminin/nidogen-1 interaction, the nidogen-binding site 
located in LE module 4 of domain III of the laminin g1 chain (Mayer et al., 1993) was 
expressed in the F9 embryoid bodies, a model for basement membrane formation. The correct 
folding of the nidogen-binding site was ensured by the additional expression of the flanking 
LE modules g1III-3 and -5. Such a polypeptide has been previously shown to fold (Stetefeld 
et al., 1996) and interact with nidogen-1 in a manner similar to native laminin-1 (Mayer et al., 
1993). In addition it was necessary to include controls which allow the distinction of specific 
phenotypes from artefacts produced by either clonal selection or through stressing the cellular 
metabolism due to expression of the recombinant protein. 
Three sets of controls were produced, F9 cells transfected with the empty expression 
vector, ones expressing a mutated, presumably inactive form of the nidogen-binding site 
(g1III3-5mut) and those expressing a similar but non-active set of three LE domains also 
present in laminin g1 (g1V1-3). The polypeptide g1III3-5mut carries the N802S point 
mutation (Poeschl et al., 1996), which reduces its binding affinity to nidogen-1 by approxi-
mately 50,000 fold. The domain V of the laminin g1 chain is comprised of four LE modules 
and has no known nidogen-binding activity. Expression of the g1V1-3 construct produces a 
laminin g1 fragment similar in secondary structure and size but of a different amino acid 
sequence to g1III3-5 (figure 2.1). 
If the present theory of basement membrane assembly is correct, i.e. nidogen-1 is a 
crucial linker between the collagen type IV and laminin networks (Yurchenco and Schittny, 
1990), these controls should distinguish a phenotype due to the disruption of laminin/nidogen-
1 binding from one caused by expression of LE rich polypeptides. 
Since specific antibodies are available only for the nidogen-binding site fragments but 
not for the detection of g1V1-3, all three laminin g1 proteins were modified by fusion with a 
N-terminal FLAG peptide which could also be utilised for affinity purification. To produce 
these constructs, the PCR amplified laminin g1 cDNA fragments were subcloned into CMV- 
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NFlag (see appendix) and then transferred into pBKEF-5 plasmid downstream of the EF1a 
promoter. 
The FLAG peptide (Hopp et al., 1988) consists of eight amino acids 
(AspTyrLysAspAspAspAspLys) of which especially Lys and Asp contribute to high 
hydrophilicity, increasing accessibility of the tag by bringing it to the protein surface (Hopp et 
al., 1986). To minimise any possible interference with the adoption of native conformation by 
the expressed protein, a small linker was placed between the FLAG tag and the LE domains. 
Similar systems have been used before for the expression of other extracellular matrix 
proteins (Yurchenco et al., 1997). 
 
 
3.1.2. Promoter activity in different cell lines 
 
F9 mouse teratocarcinoma cells are a frequently used in vitro model for the study of 
early embryogenesis, since they differentiate into primitive, visceral or parietal endoderm 
upon treatment with retinoic acid or retinoic acid and cAMP (Hogan et al., 1981; Calogero et 
al., 1991; Damjanov et al., 1994). Here various laminin g1 constructs were expressed in 
differentiating F9 cells, and their effects on basement membrane formation studied in the 
resulting embryoid bodies. 
Initially inducible expression of the polypeptides was attempted and two different 
systems were assessed. Generally such systems consist of two vectors, one encoding the gene 
of interest and the other containing so called transactivator sequences. For ecdysone-inducible 
expression the transactivator is an ecdysone receptor heterodimer comprising the VgEcR 
(ecdysone receptor modified with the VP16 transactivation domain) and the RXR (retinoid X 
receptor) receptor subunits. Transcription of these sequences is regulated by the 
cytomegalovirus (CMV) and the Rous sarcoma virus (RSV) promoters, respectively. Both 
promoters need to be active in F9 cells to induce transcription of the gene of interest. Possibly 
one or both promoters are non-functional in F9 cells as no recombinant protein could be 
detected in the cell supernatants or extracts of differentiated and undifferentiated F9 cells 
transfected with the pINDg1III3-5 and pVgRXR plasmids. Indeed, attempts to obtain F9 
subclones using CMV promoter-based lac repressor or tet responsive expression systems were 
unsuccessful (Miller and Rizzino, 1995). This suggests that the CMV promoter may be 
silenced when integrated in the genome of embryonic carcinoma cells, especially as in 293-
EBNA cells the g1III3-5 construct was successfully expressed using the CMV promoter. 
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In a second attempt to obtain inducible protein expression, a viral vector was evaluated 
in F9 cells. Unlike the conventional two plasmid system, the tet on/off retrovirus (Hofmann et 
al., 1996) contains all the components necessary for reversible induction in a single cassette. 
However, control infections with pGEM-IRES lacZ containing viruses yielded only weak 
expression in few cells. This is in agreement with one earlier study which suggested that 
embryonic carcinoma cells are difficult to transfect with retroviral vectors (Linney et al., 
1987). 
 
Other promoters used for constitutive expression in F9 cells include the simian virus 
(SV) 40 promoter (Mueller and Wagner, 1984; Gorman et al., 1985; Kindregan et al., 1994), 
the human b-actin promoter (Xu et al., 1998) and the elongation factor 1 a (EF1a) promoter 
(Niimi and Kitagawa, 1997). After testing for successful transfection and expression of a 
EF1a-GFP reporter plasmid in F9 cells (results not shown), this promoter was selected for 
expression of the laminin g1 fragments. Recombinant protein was found to be expressed in 
24% (g1III3-5), 36% (g1III3-5mut) and 16% (g1V1-3) of all the G418 resistant cell lines 
tested. This compares well with the SV40 or human b-actin promoter when used in F9 cells 
where only 4% and 2% of all resistant clones expressed detectable protein (Espeseth et al., 
1989; Kindregan et al., 1994). D3, embryonic stem cells, were also transfected with these 
constructs, such cells having a wider differentiation capacity than F9 cells. However, while 
G418 resistant clones were obtained they failed to express the fusion proteins. 
 
 
3.1.3. Protein expression in F9 mouse teratocarcinoma cells 
 
The expressed proteins were transported to the extracellular space by the presence of 
the BM40 signal peptide which has been shown previously to give highly efficient secretion 
of extracellular matrix proteins (Mayer et al., 1993; Yurchenco et al., 1997). Cell supernatants 
were collected, precipitated and tested by immunoblotting with a biotinylated mouse mono-
clonal antibody against the FLAG tag. To ensure a comparable level of expression in all 
stable F9 cell lines loading had to be standardised. Housekeeping genes like mouse b-actin or 
human GAPDH frequently used for such purposes could not be analysed since they are 
intracellular proteins. BM40 is an extracellular matrix protein constitutively expressed in 
undifferentiated F9 cells (Nishiguchi et al., 1996). Normalisation with this protein showed 
that all F9 derived cell lines synthesised and secreted approximately equal levels of the 
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laminin g1 FLAG fusion proteins (figure 2.5). It would have been interesting to know the 
molar ratio between intrinsic g1 chains and recombinantly expressed laminin g1 FLAG fusion 
proteins to assess the theoretically possible intensity of interference with the laminin/nidogen-
1 interaction. Therefore supernatants of stably expressing F9 cells lines which produce basal 
levels of laminin-1 also in the undifferentiated state (Grover et al., 1983) should be analysed 
by immunoblotting. However, this experiment could not be performed due to lack of an 
antibody which recognises the nidogen-binding site on the laminin g1 chain under reducing 
conditions. These conditions were necessary to break the disulfide bonds between the a1, b1 
and g1 chain of laminin-1 which as a whole (800kD) is too big to migrate into a 3-10% 
polyacrylamide gradient gel. 
 
The observation of equal expression of the laminin g1 FLAG fusion constructs was 
made with undifferentiated F9 cell lines while the analysis of basement membrane formation 
was done in differentiated F9 embryoid bodies. It is known that some promoters e.g. SV40 or 
adenovirus type 5 alter their activity pattern during differentiation (Niwa, 1985; Kellermann 
and Kelly, 1986). Therefore and to localise the recombinant g1III3-5 polypeptides with 
respect to nidogen-1, the expression and distribution of the FLAG tagged recombinant 
proteins were also followed in differentiated F9 embryoid bodies. With the use of a primary 
antibody directly conjugated to biotin together with a streptavidin-rhodamine detection 
system possible background problems due to the application of a mouse monoclonal antibody 
on murine tissue should be avoided. However, probably due to intrinsic biotin naturally 
occurring in mouse tissue this detection system also failed and protein expression and 
distribution in F9 embryoid bodies could not be documented. Another reason for obtaining no 
specific signals for the FLAG fusion proteins may be found in the nature of the experiment 
itself. Possibly, the produced fusion constructs were secreted to the extracellular space but not 
anchored to the pericellular matrix and therefore lost to the medium. This speculation also 
holds true for the nidogen-binding site construct g1III3-5, which could have been secreted to 
the medium either bound or not bound to nidogen-1. Metabolic labeling of nidogen-1 to 
determine any altered accumulation in the cell culture medium upon loss of anchorage to the 
basement membrane however was unsuccessful (see section 2.5.2.). 
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3.1.4. Expression and purification of the laminin g1III3-5 FLAG fusion protein from 
293-EBNA cells 
 
As observed for the FLAG tagged polypeptides g1V1-3 (Mr 18.6kD) and g1III3-5 (Mr 
19.1kD) expressed in F9 cells (figure 2.5), the g1III3-5 FLAG fusion protein expressed in 
293-EBNA cells migrated at about 25kD in SDS-PAGE. This discrepancy may be explained 
by the negative charge of the hydrophilic FLAG tag which binds fewer SDS molecules than 
marker proteins of comparable molecular weight and therefore runs higher than predicted in 
the gel (figure 2.3). To confirm the identity of the protein, serum-free supernatant of 
transfected 293-EBNA cells was collected, precipitated and tested for the presence of the 
FLAG tag by immunoblotting (figure 2.3B). 
The FLAG peptide allowed single step affinity purification of the g1III3-5 protein. 
Analysis of this affinity chromatography showed that the amount of the recombinant protein 
in the supernatant was higher than the binding capacity of the column. However, 400µg of 
FLAG tagged protein could be purified from 500ml of supernatant and only a faint band at 
67kD (figure 2.4) contaminated the eluates. Since this band probably corresponds to bovine 
serum albumin and because the FLAG fusion protein had been purified for later addition to 
fetal calf serum supplemented cell culture medium, this purity was considered sufficient. 
 
 
 
3.2. Comparison of two different embryoid body cell culture systems 
 
The need for a reproducible system to grow F9 embryoid bodies was a prerequisite. To 
find the most appropriate culture method, control cells carrying the empty expression vector 
were maintained in two different embryoid body systems. The conventional hanging drop 
technique (Hogan et al., 1983) was simple, albeit time-consuming and the numbers of 
embryoid bodies produced were low as on the average only 30 could be harvested from one 
petri-dish. Cell spin cultures were far simpler to produce in bulk. Initially the embryoid bodies 
produced were of a similar size and number, per quantity of starting cells, in both systems. 
The embryoid bodies of the cell spin system were maintained under continuous movement by 
a magnetic stirrer, which guaranteed equal distribution of oxygen and nutrients, in contrast to 
the hanging drop system where embryoid bodies were only agitated during medium changes. 
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Control embryoid bodies, grown in both systems, showed no phenotypic differences 
when analysed morphologically, for the expression and localisation of laminin-1 and nidogen-
1 or for differentiation into visceral endoderm (figure 2.6). However, when embryoid bodies 
expressing recombinant laminin g1 FLAG fusion constructs were cultured in the hanging drop 
system it became apparent, already after two days, that such embryoid bodies were smaller 
than the control (figure 2.7), while in the cell spin system there was far less divergence in 
embryoid body growth between the different clones. 
Other morphological parameters varied between the two systems, in particular in the 
formation of central cystic structures, suggesting that expression of recombinant protein 
apparently evokes non-specific morphological changes under the less optimised culture 
conditions of the hanging drop system. The greater nutrient and oxygen supply provided to 
the embryoid bodies by continuous agitation in the cell spin system, possibly compensated for 
changes in the cell metabolism exerted by recombinant expression. So to eliminate cell 
culture artefacts, it was decided to use the cell spin system for further experiments. 
 
 
 
3.3. The influence of laminin g1 FLAG fusion proteins on basement membrane 
formation and function 
 
3.3.1. Changed expression and structural organisation of basement membrane 
components 
 
Daily harvesting and immunohistochemical staining for basement membrane 
components showed that by eight days of culture, F9 embryoid bodies grown in the presence 
of retinoic acid have a distinct basement membrane directly underneath the outer layer of cells 
(results not shown). By day 12, expression had become stronger, a continuous basement 
membrane could be seen (figures 2.12 and 2.13) and the outer cells had differentiated towards 
visceral endoderm expressing cellular markers such as cytokeratin 8 (figure 2.15). Earlier 
studies suggested that F9 monolayers and cell aggregates produce laminin-1 at basal levels in 
the undifferentiated state, but treatment with 5x10-8M retinoic acid leads to a great increase in 
expression (Grover et al., 1983). Results obtained by in situ hybridisations show induction of 
laminin b1 and g1 chain and collagen type IV(a1) mRNA after four days of differentiation, 
with maximal levels occurring by day eight and followed by a decline in expression (Rogers 
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et al., 1990). However in the control embryoid bodies tested here there was little laminin seen 
expressed before six days in culture. The action of retinoic acid is probably mediated by the 
retinoic acid receptors (RARs) present in most cell nuclei. These receptors bind specific DNA 
sequences located in the promoter regions of responsive genes, some of which have been 
identified in the promoter of the laminin b1 gene (Vasios et al., 1991).  
 
In the spinner flask all F9 derived cell lines expressed laminin-1, however at varying 
levels, the embryoid bodies expressing recombinant protein apparently having a higher 
laminin-1 production than the control (figure 2.11). Strangely, upregulation of laminin-1 does 
not correlate with the presence of intact basement membranes. Laminin-1 upregulation seems 
to be independent of the recombinant protein expressed and its influence on basement 
membrane formation. All the embryoid bodies which express recombinant fragments have 
increased laminin-1 protein levels, although those from g1V1-3 and g1III3-5mut cell clones 
can form relatively intact basement membranes unlike ones expressing the g1III3-5 
polypeptide. Possibly laminin-1 upregulation is an nonspecific side effect of recombinant 
expression in the F9 embryoid body system or it is due to a feature common to all laminin g1 
fusion constructs. This question could be addressed in further expression studies. 
It may be possible that the absence of an intact basement membrane induces the cells 
to increase the production of basement membrane components via alteration in basement 
membrane receptor signalling. Indeed the receptor mediated regulation of the laminin a1 
chain has been observed in embryoid bodies raised from embryonic stem cells deficient for 
laminin receptors such as b1 integrin (Aumailley et al., 2000) or dystroglycan (Henry and 
Campbell, 1998). 
 
Surprisingly, nidogen-1 expression was unchanged at both the mRNA (figure 2.10) 
and the protein levels (figure 2.11). Recombinant expression of the nidogen-binding site 
might be expected to lead to loss of nidogen-1 into the growth medium of g1III3-5 derived 
embryoid bodies. However it is probable that nidogen-1 molecules occupied by recombinant 
nidogen-binding sites remain bound in the extracellular matrix by interactions with other 
basement membrane molecules, such as type IV collagen. 
 
Although loss of nidogen-1 from the embryoid bodies could not be detected, 
immunofluorescent analysis of the distribution of laminin-1 and nidogen-1 in the g1III3-5 
expressing clones revealed breakdown of the basement membrane. Only control and g1V1-3 
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and g1III3-5mut expressing embryoid bodies showed continuous stretches of laminin-1 
staining (figures 2.12 and 2.13). This is as expected as these polypeptides cannot bind 
nidogen-1 and therefore should not disturb the laminin/nidogen-1 interaction. The basement 
membrane disorganisation observed for g1III3-5/A and g1III3-5/B is apparent as widespread 
punctate laminin staining all over the embryoid bodies. At higher magnification (figure 2.13) 
these clones also show a partial lack of colocalisation between laminin and nidogen-1 while 
embryoid bodies derived of clones g1V1-3, g1III3-5mut or from control cells reveal precise 
codistribution. The occurrence of free laminin suggests the successful competition by the 
recombinant nidogen-binding site fragment for the binding to nidogen-1. 
 
To eliminate the possibility that this basement membrane change could be an artefact 
caused by recombinant expression per se or by the preceeding genetic manipulation, purified 
FLAG tagged g1III3-5 fusion protein was extraneously added to differentiating wild type F9 
embryoid bodies. Two day old spinner culture derived embryoid bodies were transferred into 
single wells of a 96-well plate containing 10µg/ml (0.5µM) of the affinity purified nidogen-
binding site (figure 2.4). The embryoid bodies maintained in the multi-well plate grew as 
rapidly as those in the cell spin system (figure 2.18). However, whole mount staining of these 
embyroid bodies for laminin after eight days culture in the presence of the polypeptide, 
showed a markedly disrupted laminin network (figure 2.19), indicating that the changes 
observed upon the endogenous expression of the nidogen-binding site were not artefactual 
(figure 2.12 and 2.13). 
 
These data confirm the role of nidogen-laminin binding in basement membrane 
formation since interference with this interaction causes basement membrane defects. It has 
been supposed that nidogen-1 acts as a linker molecule between the laminin and collagen type 
IV network (Aumailley et al., 1989; Yurchenco and Schittny, 1990). In vitro experiments 
using antibodies directed against the nidogen-binding site perturbed basement membrane 
formation and inhibited epithelial development in organ cultures of embryonic kidney, 
salivary gland and lung (Ekblom et al., 1994; Kadoya et al., 1997). Recent in vivo 
manipulation of the laminin/nidogen-1 interaction by the targeted removal of the nidogen-
binding g1 LE 4 module in murine embryonic stem cells (Mayer et al., 1998) leads to lethality 
in the resultant mice. While 50% of all these mutant animals die of unknown causes at or 
before embryonic day 7, possibly due basement membrane changes, the other 50% survive 
until birth, but die then or shortly afterwards. These mice show alterations in blood vessel, 
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brain, eye, kidney and lung formation, including changes in epithelial development (Mayer, 
personal communication). Surprisingly changes in basement membrane ultrastructure in these 
mice are limited, though there appears to be defects in the endothelial basement membrane in 
capillaries as well as alterations in the basement membranes of the eye (Miosge, personal 
communication). It should be noted, however, that this deletion in the g1 chain also leads to 
shortening of one of the laminin arms, which may interfere with laminin polymerisation and 
hence basement membrane assembly. 
Mice lacking nidogen-1 have also been produced and again show few alterations in 
basement membrane assembly (Murshed et al., 2000), although the retinal inner limiting 
membrane undergoes disruption (Smyth and Nischt, personal communication). Instead they 
develop seizures and other neurological defects. These surprisingly restricted changes could 
be explained by a compensatory effect of nidogen-2 (Kohfeldt et al., 1998; Kimura et al., 
1998). 
 
In the embryo, the basement membrane formed between the trophoectoderm and the 
endoderm, Reichart`s membrane (Salamat et al., 1995), is structurally similar to that formed 
under the differentiating endoderm in the F9 embryoid body both being markedly thicker than 
other basement membranes. It is interesting to speculate whether defects in this structure, 
which could be common to those in the F9 cells described here, are the cause of the 50% early 
embryonic lethality in the mice lacking the nidogen-binding site. Embryos lacking the 
basement membrane receptor a-dystroglycan die at the same time in gestation due to rupture 
of Reichart`s membrane. 
The ultrastructure of F9 cell derived basement membranes has not been as well 
characterised as that of many other basement membranes (Miosge et al., 1999). However 
basement membranes with varying ultrastructure have been identified in vivo (Ogawa et al., 
1999; Eyden, 1999), and developmental stages have also been shown in basement membrane 
formation. For example, in the six day old mouse embryo, while a classical basement 
membrane had formed between the ectoderm and the yolk sac cells in the extraembryonic part 
of the egg cylinder, no basement membrane occurred within the embryo although laminin-1 
was deposited in a linear pattern. Even at seven days the basement membrane between the 
ectodermal and the endodermal cell layers is poorly ordered (Miosge et al., 1993). In fact only 
upon the full ultrastructural development of the basement membrane was nidogen-1 found to 
be present by immungold histochemistry, suggesting that in the early embryo nidogen-1 may 
have a role in the maturation of this structure (Miosge et al., 2000a), albeit a role which is not 
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always crucial for embryonic survival. Possibly nidogen-1 is compensated for by nidogen-2 
when absent, as both proteins are often found in the same basement membranes (Kohfeldt et 
al., 1998; Miosge et al., 2000b), although to date no expression studies have been carried out 
for nidogen-2 in early embryonic development. Even though nidogen-2 synthesis by F9 cells 
has not been studied, it was reported that undifferentiated F9 cells produce a 190kD protein, 
in addition to the 150kD nidogen-1, which appeared to be either associated with, or be 
immunologically related to, nidogen-1 (Carlin et al., 1983). Synthesis of this protein stopped 
upon differentiation and only the 150kD form of nidogen could be detected at later stages. 
This suggests that nidogen-2 may be absent from the F9 embryoid bodies and so could not 
compensate for the loss of nidogen-1 upon expressing the g1III3-5 polypeptide, hence 
explaining the defects seen in the embryoid bodies described here. It should be noted that 
mice lacking nidogen-2 appear to be phenotypically normal and although only few litters from 
matings possibly resulting in animals lacking both proteins have been produced, no such 
animals have yet been born (Smyth, personal communication). 
 
 
3.3.2. Influence of the various polypeptides on differentiation 
 
For analysis of epithelial development, semithin sections were prepared from control, 
g1III3-5/A and g1III3-5mut derived embryoid bodies. Transmission light microscopy showed 
on all embryoid bodies, regardless of their ability to form intact basement membranes, smooth 
surfaces and in places microvilli (figure 2.14). This suggests that the organisation into an 
outer epithelial layer is independent of the presence of an intact basement membrane. Studies 
in embryonic stem cell derived embryoid bodies lacking the LAMC1 gene, and so unable to 
produce an intact laminin trimer, also showed the ability to form a polarised endoderm in the 
absence of a basement membrane (Murray and Edgar, 2000). The laminin receptor a-
dystroglycan, expressed by endodermal cells, is also required to produce an intact basement 
membrane, but in its absence epithelial differentiation can proceed (Henry and Campbell, 
1998). In contrast, loss of b1 integrin receptors in either F9 embryonic carcinoma or D3 
embryonic stem cell derived embryoid bodies prevented epithelial differentiation of the 
visceral endoderm as well as leading to a disruption of the basement membrane (Aumailley et 
al., 2000; Stephens et al., 1993). This suggests that signalling from certain receptors is 
required for endodermal differentiation rather than the presence of an intact basement 
membrane. It should be noted that these peripheral cells did display a-fetoprotein, an early 
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marker in epithelium formation, even in the absence of b1 integrins (Stephens et al., 1993), so 
the early stages of endoderm formation appear to be divorced from both the expression of 
these receptors and the presence of a basement membrane. 
 
TROMA-1, also called Endo A, the murine homologue of cytokeratin 8, is synthesised 
in mature visceral endoderm, after seven or eight days of culture (Oshima, 1982). g1III3-5 
embryoid bodies express the nidogen-binding site and show an altered localisation of 
TROMA-1 positive cells (figure 2.15). While control and g1V1-3 expressing embryoid bodies 
reveal strong peripheral staining, g1III3-5/A and g1III3-5/B producing clones show patchy 
staining distributed over the embryoid bodies and a reduced staining in the marginal cells. 
g1III3-5mut derived cell aggregates, which produce continuous laminin-1 deposits at their 
periphery, were difficult to interpret and showed fewer TROMA-1 positive cells than all the 
other clones (figure 2.12). However, these cavitated embryoid bodies were difficult to 
manipulate during fixation and embedding and this possibly led to epithelial detachment. 
Ectopic (stromal) TROMA-1 production in the g1III3-5 expressing embryoid bodies 
indicates a separation of expression of this usually tissue-specific gene from epithelial 
formation. In F9 embryoid bodies changes in the expression pattern of integrins (Morini et al., 
1999), Indian hedgehog (Becker et al., 1997), and extracellular matrix components such as 
laminin-1 and the collagen type IV(a1) (Rogers et al., 1990) characteristically occur 
concurrent with the formation and subsequent organisation of the visceral epithelium. 
However it is unknown if laminin is necessary to trigger TROMA-1 synthesis. A 
colocalisation of TROMA-1 and laminin in g1III3-5 derived embryoid bodies could indicate a 
role for laminin in influencing cytokeratin 8 expression. TROMA-1 typically occurs late in 
endoderm formation (Kemler et al., 1981) and the change of its expression pattern in the 
embryoid bodies producing the g1III3-5 polypeptide, suggests alterations in differentiation 
despite the normal appearance of the endoderm. This implies that TROMA-1 synthesis does 
require the presence of an organised basement membrane. Cytokeratin 8 is expressed by early 
embryonic epithelia, however in its absence differentiation in these tissues appears to occur 
normally (Baribault et al., 1993; Baribault et al., 1994; Brock et al., 1996; Hesse et al., 2000), 
this suggests that the endoderm formed in these embryoid bodies could in other respects be 
normal. Immunostaining for a-fetoprotein, a visceral endoderm marker for which many 
publications report differentiation-specific upregulation at the mRNA level, failed, probably 
due to its loss into the growth medium. 
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Transmission light microscopy of 12 day old embryoid bodies revealed cavity 
formation, seen as bright central regions in the control, g1V1-3 or g1III3-5mut expressing 
clones (figures 2.9). No cavities occured in g1III3-5/A and g1III3-5/B derived embryoid 
bodies which show disrupted basement membranes. Lucifer Yellow VS staining showed large 
central necrotic cell areas in these clones, while this was absent or far less apparent in the 
cavity forming embryoid bodies (figures 2.9). Further necrosis appears only to occur where 
intact basment membranes are absent (figures 2.12 and 2.13). 
There are two views of cavitation in the early mouse embryo, based upon experiments 
in embryoid bodies. In the first a soluble signaling molecule, possibly BMP-4 (Coucouvanis 
and Martin, 1999), originating from the outer endodermal cell layer of the implanted 
blastocyst, is thought to induce apoptosis of the inner ectodermal cells. An opposing signal, 
mediated by contact with the basement membrane, leads to survival of the more peripheral 
ectodermal columnar cells which line the cavity and contact the basement membrane 
(Coucouvanis and Martin, 1995). In the second theory, the polarisation of the ectoderm 
requires a basement membrane, this induces separation and the apoptotic death of the 
underlying central non differentiated cells. Here BMP-4 either plays no role, or without a 
basement membrane is unable to induce differentiation or apoptosis (Murray and Edgar, 
2000). 
The results presented here show that with the disruption of the basement membrane, 
there is impairment of cavity formation which finally results in the embryoid body exceeding 
its nutritional supply and undergoing central necrosis (figure 2.9). This is in agreement with 
the second theory of cavity formation based upon studies with LAMC1-/- embryoid bodies 
which are also unable to form basement membranes and so fail to cavitate. 
 
PECAM-1 (platelet/endothelial cell adhesion molecule-1; Tang and Honn, 1995) 
staining was performed despite a lack of reports on endothelial differentiation in F9 embryoid 
bodies. These experiments revealed PECAM-1 expression in all clones but at varying levels. 
Embryoid bodies formed by g1V1-3 or g1III3-5 expressing cells and the control show a 
similar pattern of staining with a marked increase between days 10 and 12. g1III3-5mut shows 
highest signal intensities, but its differentiation state might be distinct from the other clones 
due to pronounced cavity formation. However, the PECAM-1 staining did not show vessel-
like structures due to the limited differentiation repertoire of F9 embryoid bodies. Still, it was 
a valuable tool in determining the reproducibility of F9 cell differentiation in the cell spin 
system. 
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3.3.3. Influence on the permeability properties of basement membranes 
 
The function of basement membranes as a filtration barrier was tested by use of a 
diffusion assay. Embryoid bodies expressing the laminin g1 FLAG fusion proteins as well as 
control ones were incubated with dextran molecules of 10 and 70 kD. Analysis of diffusion 
distances into the embryoid bodies by laser scanning microscopy and calculation of the 
diffusion coefficients were used to compare the permeability properties of all F9 derived 
clones (figure 2.17). This showed that basement membranes synthesised by control and g1V1-
3 expressing embryoid bodies were the most effective diffusion barriers for both 10 and 70kD 
dextrans. Expression of the nidogen-binding site construct g1III3-5 increased diffusion rates, 
which can be explained by the disrupted basement membranes (figure 2.12 and 2.13). 
Analysis of clone g1III3-5mut, which shows continuous laminin-1 deposition all around the 
embryoid body, was impaired by its extensive cavitation at the time of analysis (figure 2.12) 
The diffusion coefficients of about 5x10-8cm2/sec for control or g1V1-3 derived embryoid 
bodies and 1x10-7cm2/sec for the g1III3-5 expressing clones fit to inhibited and facilitated 
diffusion, respectively, as previously measured for embryonic stem cell embryoid bodies 
(Wartenberg et al., 1998a). 
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3.4. Perspectives 
 
Before starting further complex experiments investigating in vivo the role of the 
laminin/nidogen-1 interaction, it would be interesting to determine if F9 embryoid bodies 
produce nidogen-2. While this has a 100 to 1000 fold lower affinity for the nidogen-1 binding 
module g1III4, it can also bind to the laminin g1 chain via a second epitope, as well as interact 
with collagens type I and IV and perlecan (Kohfeldt et al., 1998). If nidogen-2 is expressed, 
this would indicate that the recombinant nidogen-binding site is very efficient in blocking 
both nidogens in their basement membrane stabilising function. If not, detailed studies of 
basement membrane formation in nidogen-1/nidogen-2 double null mutant mice will help to 
understand further the interplay between both nidogens and laminin and the type IV collagen 
network. 
To date the role of basement membrane components involved in epithelial differen-
tiation has been studied by antibody perturbation in organ culture experiments. Also recent 
results from skin organ cultures have shown that the recombinant g1III3-5 nidogen-binding 
site fragments could interfere with basement membrane formation between keratinocytes and 
fibroblasts in a manner similar to that described in this thesis (Breitkreutz, personal 
communication). It would be interesting to understand, how the basement membrane 
influences cellular differention in vivo and how this is effected by basement membrane dis-
ruption. This could be addressed by the production of a transgenic animals expressing the 
nidogen-binding site under the control of e.g. a mammary/lactation-specific promoter. 
Mammary-specific disruption of the basement membrane has the additional advantage that it 
is unlikely to be lethal, and that male animals can transmit the transgene in the event that 
females are unable to lactate and so fail to rear offspring. Further the mammary epithelium 
highly active can be monitored throughout its cyclical development. 
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4. Materials and Methods  
 
4.1. Culture and maintenance of tissue culture cell lines 
 
4.1.1. Mouse teratocarcinoma cell line  
 
Mouse teratocarcinoma F9 (CRL 1720; American Type Culture Collection; DSM 
ACC 112) cells were plated on gelatinised dishes, cultured in DMEM containing 200U/ml 
penicillin, 200µg/ml streptomycin, 2mM L-glutamine and 10% fetal calf serum (GIBCO 
BRLÔ) and grown at 37°C in a humified incubator with a 5% CO2 atmosphere. For embryoid 
body cultures, untransfected F9 cells were maintained in normal growth medium supplied 
with 5x10-8M all-trans retinoic acid (R-2625; Sigma-Aldrich) for 12 days either using the cell 
spin system (Integra Bioscience) or the hanging drop method (Hogan et al., 1994). 
 
In the cell spin system embryoid body cultures are started with 100ml of single cell 
suspensions of about 1.2x105 cells/ml in siliconated spinner flasks. After one day when small 
aggregates have formed, more growth medium is added up to a volume of 250ml and changed 
daily. In this system embryoid bodies are maintained under continuous agitation by magnetic 
stirring which guarantees optimal nutrition and oxygen support. 
The hanging drop method starts with 20µl cell suspensions of 1.5x105 cells/ml which 
hang on a petri-dish. After two days when these drops contain small cell aggregates 10ml 
medium is added and changed every second day till the embryoid bodies are harvested. 
 
 
4.1.2. Human embryonic kidney cell line  
 
293-EBNA cells (Invitrogen) were cultured in DMEM-F12 containing 200U/ml 
penicillin, 200µg/ml streptomycin, 20mM L-glutamine, 10% FBS (GIBCO BRLÔ) and 
50µg/ml G418 (GIBCO BRLÔ) at 37°C in a humified incubator with a 5% CO2 atmosphere. 
After transfection, to maintain expression in 293-EBNA cells transfected with the g1III3-5 
construct, G418 was removed and the cells were treated with 0.5µg/ml puromycin (Sigma-
Aldrich). 
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4.1.3. Establishment of stably transfected cell lines 
 
1x106 cells were electroporated with 5µg circular plasmid DNA in 800µl growth 
medium using the Gene PulserÒ II and 0.4cm cuvettes (Biorad). Resistance and voltage were 
set to 500µF and 230V, respectively and time constants of approximately 7sec were obtained. 
For F9 cells, selection was initiated 24 h after electroporation with medium containing 
1mg/ml G418 (GIBCO BRLÔ). G418 resistant clones were picked, expanded and screened 
by immunoblotting and positive clones were frozen in liquid nitrogen. 293-EBNA cells which 
do not allow clonal selection were expanded during selection with puromycin (Sigma-
Aldrich) at a concentration of 0.5µg/ml. 
 
 
4.1.4. Thawing and freezing cells 
 
Frozen cells were quickly transferred from liquid nitrogen into a 37°C waterbath, 
thawed, washed with prewarmed growth medium and seeded on tissue culture plates 
(Greiner). For the purpose of freezing, cells were trypsinised, resuspended in growth medium 
supplemented with 20% fetal calf serum (GIBCO BRLÔ) and 10% DMSO (Sigma-Aldrich) 
and slowly cooled to -80°C. After overnight incubation at -80°C, cells were kept in liquid 
nitrogen for long term storage. 
 
 
 
4.2. Molecular cloning 
 
4.2.1. Bacterial cell culture  
 
The bacterial strain DH5a was grown following the instructions of Sambrook et al. 
(1989). For transformation and production of competent E.coli cells the method of Hanahan 
(1983) was applied. 
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4.2.2. DNA preparation 
 
Small amounts of plasmid DNA (10µg) were isolated from 2ml E.coli cultures 
following the protocol of Birnboim (1983). For production of up to 100µg of plasmid DNA 
the Midi-Prep Kit (Macherey and Nagel) was used. The DNA concentration was measured 
photometrically at 260nm and calculated on the basis of the assumption that an optical density 
of 1 equals a concentration of 50µg/ml double stranded DNA. DNA gel electrophoresis with 
1kb DNA ladder (GIBCO BRLÔ) was performed in 1x TAE buffer as described in Sambrook 
et al. (1989). 
 
 
4.2.3. RNA preparation and northern blot analysis 
 
Total RNA was isolated from 12 day old, differentiated F9 derived embryoid bodies 
following the protocol of Chomczynski and Sacchi (1987) and resuspended in diethyl 
pyrocarbonate (DEPC)-H2O. The concentration was calculated from the optical density at 
260nm assuming that an OD value of 1 corresponds to 40µg/ml RNA. Gel electrophoresis of 
20µg RNA on a 1% formaldehyde agarose gel with 0.24-9.5 kb RNA Ladder (GIBCO 
BRLÔ), RNA transfer to a nylon membrane by vacuum blotting and northern blot analysis 
were performed as described in Sambrook et al. (1989). Membranes were probed with a 
[a32P]dCTP labeled DNA probes for mouse nidogen-1 and human GAPDH which served as a 
loading control. Bands were detected using autoradiography. 
 
 
4.2.4. Labeling of DNA probes 
 
DNA probes were labeled with [a32P]dCTP (Hartmann Analytic) by random priming 
as reported by Feinberg and Vogelstein (1983) using the LaddermanÔ Labeling Kit (TaKaRa 
Shuzo Co., Ltd.). For standardisation of loading a 500bp HindIII/XbaI fragment of human 
GAPDH (gene bank accession number AJ005371) was isolated and labeled. A 1154-bp PCR 
product of mouse nidogen-1 cDNA using AGA ATC CAT GCT ACA TTG GC (sense) and 
TGG GTG CCA TCC ATC TTT GC (antisense) primers of the protein coding region served 
as a DNA probe for nidogen-1 mRNA (gene bank accession number: X14480). 
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4.2.5. Polymerase chain reaction (PCR) 
 
Oligonucleotides were ordered at MWG-Biotech AG in highly purified salt free 
quality and primer concentration was determined photometrically at 260nm assuming that an 
optical density of 1 equals 37µg/ml single stranded DNA. Since only fragments below 2kb 
were amplified, Taq polymerase (Perkin Elmer; Roche) was used at a concentration of 
0.05U/µl in combination with 0.25µM primer, 0.125mM dNTP mix (Pharmacia), 1x reaction 
buffer supplemented with 0.15mM MgCl2 (Perkin Elmer; Roche) and 10ng plasmid DNA in 
100µl reaction volume. Using the RoboCyclerÒ Gradient 40 (Stratagene) the template DNA 
was denatured at 95°C for 2min followed by 30 amplification cycles each comprising 1min 
incubation at 95°C, 1min at annealing temperature and 1min at 72°C. Per kb fragment length 
an elongation time of 1min was calculated and the annealing temperature was defined by 
addition of 3°C to the lowest melting temperature Tm = 4x(G+C) + 2x(A+T). 
 
 
4.2.6. Recombinant techniques 
 
All DNA modifying enzymes (e.g. restriction enzymes, T4 DNA ligase and T4 
polynucleotide kinase) were obtained from New England Biolabs and used following the 
manufacturers instructions. Site directed mutagenesis was performed using the TransformerÔ 
Site-Directed Mutagenesis Kit (Clontech Laboratories, Inc.). DNA sequences were deter-
mined in the service laboratory of the ZMMK (Center for Molecular Medicine Cologne) using 
an ABI PrismÔ 377 DNA Sequencer (Applied Biosystems). Sequences were analysed using 
the Wisconsin Sequence Analysis Package, Version 8.1 (Genetics Computer Group, Inc.). 
 
 
 
4.3. Microscopy 
 
4.3.1. Preparation of cryosections  
 
After a brief wash in 1x PBS, pH 7.4, embryoid bodies were incubated in 1% 
paraformaldehyde for 30min at room temperature, rinsed in 1x PBS, pH 7.4, twice, trans-
ferred into Tissue Tek (Sakura) via stepwise incubation in 5% sucrose for 24h at 4°C, in 20% 
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sucrose for 2h at 37°C, and for 1h at 37°C in a 1:1 mix of Tissue Tek and 20% sucrose. All 
sucrose solutions were prepared in 1x PBS, pH 7.4, supplemented with 0.05% sodium azide. 
After 1h incubation in Tissue Tek embryoid bodies were frozen in liquid nitrogen and stored 
at -80°C. Subsequent cryosectioning with a LEICA CM3050 cryostat was performed to obtain 
7µm sections which were collected on Shandon histoslides (Life Science) and stored at -20°C. 
 
 
4.3.2. Preparation of semithin sections  
 
After overnight fixation in 2% paraformaldehyde, 1% glutardialdehyde, 0.2% picric 
acid (Sigma-Aldrich) in 0.1M HEPES buffer and three subsequent washes in 0.1M HEPES 
buffer each for 20min, embryoid bodies were dehydrated in 50% ethanol for 10min, in 70% 
ethanol supplemented with 1% uranyl acetate overnight followed by 10min incubation in 90% 
ethanol and 3x 10min in 100% ethanol. After dehydration the embryoid body material was 
immersed into a 1:1 mix of propylene oxide and ethanol for 2x 10min, into propylene oxide 
for 2x 10min followed by a 1:1 mix of araldite and propylene oxide for 6h and 2h incubation 
in araldite at 40°C. Subsequent polymerisation proceeded for 12h at 45°C and 48h at 60°C. 
Semithin sections of 1µm thickness were produced with an ultramicrotome (type OMU 3, 
Reichert), stained with methlyene blue (Romeis, 1989) and analysed with transmission light 
microscopy using an Axiovert Microscope (Zeiss). In addition transmission light microscopy 
with an Achrostigmat 10x/0.25NA objective was used to determine morphology of embryoid 
bodies still floating in growth medium. 
 
 
4.3.3. Immunofluorescence staining 
 
A rabbit polyclonal antiserum to laminin-1 (M. Paulsson, Cologne), a rat monoclonal 
anti-nidogen [entactin] G2 domain antibody (MAB 1884; Chemicon), a rat monoclonal 
TROMA-1 antibody (Kemler et al., 1981) and a purified rat anti-mouse CD31 (PECAM-1) 
monoclonal antibdoy (Cat.No. 01951D; Pharmingen) served as primary antibodies. As secon-
dary antibodies DTAF-conjugated goat anti-rabbit IgG, Cy3ä-conjugated goat anti-rabbit 
IgG, Cy3ä-conjugated goat anti-rat IgG and Cy5Ô-conjugated syrian hamster anti-rat IgG 
(all Jackson Immuno Research Laboratories, Inc.) were used. All stainings were performed 
using 1x PBS, pH 7.4, as a buffer system. 
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For whole mount stainings embryoid bodies were fixed in ice-cold methanol:acetone 
(7:3) for 1 h at -20°C, washed with 0.1% Triton-X 100 and either stored in PBS at 4°C or 
blocked in 10% milk powder for 1h. After that embryoid bodies were incubated with the 
primary antibody for 1.5 h on a rocking device, washed with 0.01% Triton-X 100, incubated 
with the second antibody for 1h, washed again and stored in PBS at 4°C. For analysis a laser 
scanning confocal microscope (LSM 410; Zeiss) with a Plan-Neofluar 25x/0.8NA objective 
and 4.5x zoom was used in case of laminin-1. PECAM-1 staining was scanned using a 
16x/0.5NA objective and a method called "extended type of focus". For that purpose five 
serial sections of 20µm thickness through single embryoid bodies were examined for 
PECAM-1 signals and their overlay used to detect three dimensional vascularised tissues. The 
percentage of total area stained for PECAM-1 was determined with the computer programme 
LSM DUMMY (Zeiss) which was also used for the determination of embryoid body size. 
 
7µm cryosections were briefly fixed with 0.5% paraformaldehyde and blocked with 
5% normal goat serum (ICN, Biomedicals) and 0.2% Tween for 30min. The primary antibody 
was applied for 1h followed by three washes with the blocking solution. The sections were 
incubated with the secondary antibody for 45min, washed, mounted in fluorescent mounting 
medium (DAKO) and examined using a Axiophot Microscope (Zeiss) equipped with a 
fluorescent light source. 
 
 
4.3.4. Staining for cell death and viability 
 
Two fluorescent dyes were used to detect dead cells, Lucifer Yellow VS (Sigma-
Aldrich) and SYTOX (Molecular Probes, Inc.). Lucifer Yellow VS is a highly charged, 
hydrophilic dye which cannot pass through hydrophobic membranes and is excited at a 
wavelength of 450nm (Stewart, 1981). It diffuses into dead cells with disrupted plasma 
membranes and remains in necrotic cell areas due to high binding affinity to SH-groups. 
Lucifer Yellow VS was added to embryoid bodies floating in growth medium to a final 
concentration of 180µM, incubated for 40min at room temperature in darkness and removed 
in two washing steps with growth medium. Embryoid bodies were then incubated overnight in 
normal growth conditions to remove any Lucifer Yellow VS incorporated by endocytosis into 
viable cells. Embryoid bodies were analysed by means of laser scanning microscope with a 
Plan-Neofluar 25x/0.8NA objective at a wavelength of 488nm. 
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SYTOX green nucleic acid stain penetrates cells with compromised plasma 
membranes, intercalates into DNA and upon binding to double stranded DNA its fluorescence 
intensity increases 1000 times. Necrotic cell areas where DNA has mostly been degraded do 
not react with SYTOX. Thus it can be used to detect single dead cells in otherwise intact 
tissue. SYTOX was added to embryoid bodies floating in growth medium at a final 
concentration of 0.5µM, incubated for 10min at 37°C and analysed by means of laser 
scanning microscope with a Plan-Neofluar 25x/0.8NA objective when excited with the 488nm 
wavelength of the argon-ion laser. 
 
 
 
4.4. Diffusion assay 
 
After 8 days of culture, embryoid bodies were rinsed in E1 solution (135mM NaCl, 
5.4mM KCl, 1.8mM CaCl2 x 2 H2O, 1mM MgCl2 x 6 H2O, 10mM glucose, 10mM HEPES, 
pH 7.5), transferred into 10µM rhodamine dextran solution of either 10kD (neutral D-1824; 
Molecular Probes, Inc.) or 70kD (neutral D-1841; Molecular Probes, Inc.), incubated for 5 
minutes, briefly washed twice in E1 solution to reduce background staining and analysed with 
a laser scanning microscope (LSM 410; Zeiss) by means of the optical probe technique 
(Wartenberg et al., 1998b). Based on the property of the laser scanning microscope to produce 
series of optical sections of defined thickness and precise distance from each other throughout 
the embryoid body, small regions of interest (600µm2 = 40x40 pixel) are analysed in z-
orientation at a distance of 10µm. The mean fluorescence intensity in each region of interest is 
measured from the embryoid body surface to its center, plotted against the penetration depth 
of the laser beam and depicted in a graph from which the diffusion distance can be derived. 
The diffusion coefficient may then be calculated based on the Einstein and Smoluchowski 
equation D = x2/2t, where x describes the distance of diffusion in a distinct time period t. 
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4.5. Protein chemistry 
 
4.5.1. Affinity chromatography 
 
The FLAG fusion protein laminin g1III3-5 was expressed in 293-EBNA cells (see 
6.1.3.) using the CMV promotor (Smyth et al., 2000) and by use of the BM40 signal peptide 
secreted to the medium after passing the Golgi apparatus. Serum-free supernatant was 
dialysed overnight (molecular weight cut off of 12-14kD), centrifuged and loaded onto a anti-
FLAG M2 agarose affinity column (A1205; Sigma-Aldrich) buffered in TBS, pH 7.4. Non-
binding proteins were washed away using TBS, pH 7.4, while bound FLAG tagged protein 
was eluted with 100µg/ml FLAG peptide (F3290; Sigma-Aldrich) following the manu-
facturers instructions. 
 
 
4.5.2. Treatment of wild type F9 embryoid bodies with affinity purified FLAG fusion 
protein g1III3-5 
 
Untransfected F9 cells were grown to confluency, trypsinised and transferred into the 
cell spin system (Integra Bioscience) where 5x10-8M all-trans retinoic acid (R-2625; Sigma-
Aldrich) was added to induce differentiation. At day two of culture embryoid bodies were 
transferred into single wells of a 96-well plate filled with 100µl normal cell culture medium 
supplemented with affinity purified FLAG fusion protein g1III3-5 at a concentration of 
10µg/ml. The medium was changed daily to ensure a maintained concentration of retinoic 
acid and peptide. 
 
 
4.5.3. Immunoblot analysis 
 
To determine the expression level of laminin g1-FLAG fusion proteins in supernatants 
of transfected F9 cells these were TCA precipitated and separated by SDS-PAGE on a 15% 
polyacrylamide gel. Proteins were transferred onto nitrocellulose membranes and probed with 
10µg/ml BioM2 monoclonal antibody against the FLAG epitope (F9291; Sigma-Aldrich) and 
a rabbit polyclonal antiserum against mouse BM40 (Nischt et al., 1991). For determination of 
the endogenous level of laminin-1 and nidogen-1, embryoid bodies were homogenised with 
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0.15M NaCl in 50mM Tris/HCl, pH 7.4. The homogenates were diluted 1:1 (v/v) in Laemmli 
sample buffer (1970), submitted to SDS-PAGE on a 3-10% polyacrylamide gel in the pre-
sence of 5% b-mercaptoethanol, transferred to nitrocellulose and incubated with a rabbit 
polyclonal antiserum against laminin-1, a rat monoclonal antibody against the nidogen 
[entactin] G2 domain (MAB 1884; Chemicon) and a mouse monoclonal antibody against 
human actin (sc-8432; Santa Cruz Biotechnology, Inc.). As secondary antibodies either 
streptavidin-biotinylated horseradish peroxidase (HRP) complexes (RPN1051; Amersham 
Life Science) or HRP conjugated immunoglobulins from swine anti-rabbit (P0399; DAKO), 
rabbit anti-rat (P0450; DAKO) or rabbit anti-mouse (P0260; DAKO) immunoglobulin G 
antisera were used. Immunoreactive proteins were detected using the ECL chemiluminescent 
detection system. 
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5. Appendix 
 
5.1. Abbreviations 
 
A adenosine 
BM40 basement membrane protein 40kD 
C cytidine 
cDNA complementary DNA 
CMV cytomegalovirus 
dCTP desoxycytosintriphosphate 
DMEM Dulbecco`s modified Eagle medium 
DMSO dimethylsulfoxide 
DNA desoxyribonucleic acid 
dNTP desoxyribonucleotidtriphosphate 
EBNA Epstein Barr nuclear antigen 
EDTA ethylenediaminetetraacetic acid 
EF 1a elongation factor 1 a 
EGF epidermal growth factor 
EHS Engelbreth-Holm-Swarm 
F Farad 
FBS fetal bovine serum 
G guanosine 
G418 geneticin 
GAPDH glycerinaldehydephosphate dehydrogenase 
GFP green fluorescent protein 
HRP horseradish peroxidase 
kB kilobases 
kD kilodalton 
LE laminin EGF-like 
MCS multiple cloning site 
mRNA messenger RNA 
NF200 neurofilament 200 
OD optical density 
PAGE polyacrylamide gel electrophoresis 
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PBS phosphate buffered saline 
PCR polymerase chain reaction 
PECAM-1 platelet/endothelial cell adhesion molecule 1 
RNA ribonucleic acid 
RSV Rous sarcoma virus 
SDS sodium dodecyl sulfate 
T thymidine 
Taq Thermophilus aquaticus 
TBS tris buffered saline 
TCA trichloric acid 
Tm melting temperature 
TROMA-1 trophoectodermal marker 1 
 
 
5.2. Amino acid code 
 
A Ala Alanine M Met Methionine 
C Cys Cysteine N Asn Asparagine 
D Asp Aspartic acid P Pro Proline 
E Glu Glutamic acid Q Gln Glutamine 
F Phe Phenylalanine R Arg Arginine 
G Gly Glycine S Ser Serine 
H His Histidine T Thr Threonine 
I Ile Isoleucine V Val Valine 
K Lys Lysine W Trp Tryptophane 
L Leu Leucine Y Tyr Tyrosine 
 
 
 
 
 
 
 
 
 
67
5.3. Vectors  
Ampicillin
ColE1 origin
MCS
f1(+)origin
lacZ
pBluescript KS(+)
XhoI
HindIII
KpnI
SacI
2958bp
EF1 alpha
Promoter
GCSF
Poly(A)
ColE1 origin
Neo(R)
f1(-)origin
SV40 ori
bla(R)Promoter
pBKEF-5 Kan(R)
TK Poly(A)
NotI
MluI
SspI
SspI
EcoRI
BamHI, HindIII, XbaI, SalI
Ampicillin
ColE1 origin
HindIII
oriP
SV40 p(A)
pCEP-Pu
EBNA-1
NotI
Pac
NheI
SV40 p(A)
PSV40
pCMV
BM40
signal
peptide5' UTR
XhoI
Ampicillin
ColE1 origin
HindIII
oriP
SV40 p(A)
CMV-NFlag
EBNA-1
NotI
Pac
NheI
SV40 p(A)
PSV40
pCMV
BM40
signal
peptide5' UTR
XhoI
Flag tag
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